Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016616	s-dheas	umol/l (umol/l)	2440	3066	0.03%
3016616	s-dheas	— (—)	271	332	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Female infertility

571

473

7.68

317.57

1.2

6.27

5.16

umol/l

6.23

533

432

Polycystic ovarian syndrome, broad definition

527

438

13.30

307.65

1.2

1.1

6.67

6.07

umol/l

2.22

503

409

Female infertility, associated with anovulation

369

220

18.45

307.65

1.2

6.25

6.05

umol/l

0.30

352

201

Benign neoplasm of other and unspecified endocrine glands

285

152

19.80

307.65

1.2

1.4

2.58

4.61

umol/l

8.79

263

142

Benign neoplasm of other and unspecified endocrine glands

285

146

20.62

307.65

1.2

1.4

2.58

4.51

umol/l

7.85

263

138

Polycystic ovarian syndrome, consortium definition

941

1241

4.66

307.65

1.3

1.2

6.28

4.83

umol/l

16.71

873

1145

Polycystic ovarian syndrome

351

240

17.00

307.65

1.2

1.1

6.97

6.29

umol/l

1.58

330

222

Ovarian dysfunction

370

303

13.64

307.65

1.3

1.1

6.86

6.01

umol/l

2.69

349

281

Disorders of other endocrine glands

772

950

8.25

307.65

1.5

1.2

5.36

5.08

umol/l

0.96

713

874

Exclusions for E4_PCOS_BROAD

334

401

8.67

257.94

1.9

1.3

4.24

5.03

umol/l

2.23

302

366

Endocrine, nutritional and metabolic diseases

815

930

4.51

255.43

1.3

1.2

5.76

5.65

umol/l

0.29

763

864

Amenorrhoea

229

169

14.50

248.55

1.3

1.2

5.95

5.98

umol/l

0.03

212

155

Irregular menses

584

1136

4.24

204.39

1.3

5.80

4.99

umol/l

4.80

545

1050

Other disorders of adrenal gland

130

23.01

176.33

2.2

1.7

3.34

4.94

umol/l

2.16

111

Noninflammatory disorders of female genital tract

521

626

4.25

151.93

1.2

1.3

6.25

5.47

umol/l

3.44

486

574

Female infertility, cervigal, vaginal, other or unspecified origin

350

445

5.37

148.89

1.2

6.17

5.02

umol/l

5.49

325

407

Other nutritional deficiencies

516

1719

2.96

111.54

1.3

5.42

5.14

umol/l

0.79

477

1588

Obesity and other hyperalimentation

493

1649

2.99

108.57

1.3

5.49

5.09

umol/l

1.28

454

1523

Obesity

488

1644

2.97

106.27

1.3

5.51

5.10

umol/l

1.38

450

1518

Hypopituitarism

107

12.05

105.27

1.8

1.5

4.07

4.73

umol/l

0.77

Disorders of skin appendages

425

1348

3.19

104.74

1.3

6.43

5.27

umol/l

4.16

398

1244

Hypothyroidism (congenital or acquired)

314

487

3.75

83.33

1.4

1.2

5.69

6.33

umol/l

1.91

296

457

Anxiety disorders, excluding more controls

541

1396

2.59

82.63

1.4

1.3

5.24

5.17

umol/l

0.13

496

1307

Hypothyroidism, levothyroxine purchases

308

482

3.72

80.93

1.4

1.2

5.73

6.36

umol/l

1.88

291

452

Hypothyroidism and >3 levothyroxin purchases

308

482

3.72

80.93

1.4

1.2

5.73

6.36

umol/l

1.88

291

452

Anxiety disorders

602

1791

2.40

79.97

1.4

1.3

5.29

5.16

umol/l

0.36

555

1656

Neurotic, stress-related and somatoform disorders

599

1786

2.40

79.79

1.4

1.3

5.31

5.17

umol/l

0.37

553

1650

Anxiety (asthma-related co-morbidities)

473

1433

2.62

77.70

1.4

1.3

5.57

5.54

umol/l

0.06

434

1335

Obesity due to excess calories

358

1237

2.92

76.22

1.3

5.47

5.19

umol/l

0.61

327

1139

All anxiety disorders

482

1582

2.47

70.49

1.4

1.2

5.57

5.52

umol/l

0.08

443

1470

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

241

703

3.47

68.31

1.6

1.3

4.09

4.53

umol/l

1.02

225

649

Recurrent or chronic depression

292

662

3.21

67.27

1.3

1.2

5.30

5.74

umol/l

0.89

260

618

Depression

584

1815

2.23

65.37

1.3

1.2

5.13

5.23

umol/l

0.25

527

1691

Disorders of the thyroid gland

583

1712

2.24

65.14

1.4

1.2

4.94

5.35

umol/l

1.22

539

1585

Excessive, frequent and irregular menstruation

326

591

3.10

64.98

1.3

1.2

5.79

5.36

umol/l

1.10

307

540

Mood disorders, excluding more controls

535

1400

2.34

64.84

1.3

1.2

5.02

5.16

umol/l

0.33

482

1311

Medical observation and evaluation for suspected diseases and conditions

415

791

2.70

63.90

1.4

1.2

5.15

5.46

umol/l

0.74

378

744

Mood disorders

601

1829

2.17

62.44

1.3

1.2

5.09

5.20

umol/l

0.27

545

1704

Mood [affective] disorders

599

1829

2.16

61.96

1.3

1.2

5.10

5.21

umol/l

0.25

543

1704

Obesity, other/unspecified

258

842

3.10

60.93

1.4

1.3

5.41

5.06

umol/l

0.73

238

778

Hypothyroidism, other/unspecified

549

1642

2.22

60.35

1.5

1.2

4.92

5.34

umol/l

1.16

502

1521

Hypothyreosis and Thyroxine purchase for inclusion criteria

559

1712

2.17

58.00

1.5

1.2

4.88

5.28

umol/l

1.11

512

1587

Hyperfunction of pituitary gland

7.88

53.30

1.6

1.2

5.42

5.31

umol/l

0.07

Medical treatment for female infertility

256

908

2.86

52.14

1.3

5.68

5.46

umol/l

0.49

238

839

Biguanides

419

1132

2.29

48.96

1.3

4.84

4.43

umol/l

1.17

384

1041

Other anxiety disorders

374

1443

2.32

48.64

1.4

1.2

5.99

5.69

umol/l

0.80

342

1340

Other (not insulin) diabetes medications

426

1140

2.26

48.10

1.3

4.85

4.45

umol/l

1.15

388

1050

Used for control exclusion in common control thyroid runs

611

1562

1.99

47.76

1.4

1.2

5.03

5.56

umol/l

2.55

563

1453

Type 2 diabetes

459

1256

2.18

47.25

1.3

1.2

4.86

4.65

umol/l

0.47

418

1160

Genitourinary diseases

325

626

2.61

47.00

1.3

5.53

5.01

umol/l

1.43

305

575

Type 2 diabetes, definitions combined, including avohilmo

416

1118

2.21

44.40

1.2

1.3

4.87

4.50

umol/l

0.98

382

1027

Type 2 diabetes, strict (exclude DM1)

407

1097

2.22

44.12

1.2

1.3

4.87

4.45

umol/l

1.17

373

1010

Type 2 diabetes, definitions combined

405

1091

2.22

43.91

1.2

1.3

4.88

4.46

umol/l

1.17

371

1005

Headache

409

1615

2.13

42.97

1.4

1.2

5.00

5.43

umol/l

0.90

374

1494

Hypothyroidism, strict autoimmune

429

1348

2.12

42.32

1.4

1.1

5.10

5.54

umol/l

0.94

389

1257

Diseases of the skin and subcutaneous tissue

559

1448

1.94

40.85

1.3

1.2

5.34

5.08

umol/l

0.78

515

1337

Any mental disorder

560

1453

1.94

40.54

1.3

4.92

5.06

umol/l

0.34

501

1355

Depression medications

266

502

2.69

40.47

1.4

1.2

5.99

6.42

umol/l

0.92

242

472

General examination and investigation of persons without complaint and reported diagnosis

342

791

2.31

39.28

1.4

1.2

5.01

5.46

umol/l

1.19

313

744

Pain and other conditions associated with female genital organs and menstrual cycle

161

494

3.16

39.17

1.3

1.2

5.96

5.59

umol/l

0.56

152

451

Psychiatric diseases

553

1448

1.92

39.04

1.3

4.96

5.06

umol/l

0.23

495

1347

Depression or dysthymia

324

789

2.31

37.66

1.4

1.2

4.93

5.18

umol/l

0.48

289

737

Selective serotonin reuptake inhibitors

511

1400

1.93

37.10

1.3

1.2

5.32

umol/l

0.00

463

1310

Special screening examination for infectious and parasitic diseases

209

582

2.71

36.39

1.2

1.1

5.91

6.42

umol/l

1.14

195

549

Diabetes medication

491

1574

1.90

35.57

1.3

4.83

4.79

umol/l

0.08

444

1455

Diabetes mellitus

498

1575

1.89

35.41

1.3

4.85

umol/l

0.00

450

1456

Other special examinations and investigations of persons without complaint or reported diagnosis

343

791

2.20

34.88

1.4

1.2

5.06

5.46

umol/l

1.10

317

744

Examination and observation for other reasons

296

790

2.29

34.60

1.3

1.2

4.77

5.46

umol/l

2.23

268

743

Diabetes, varying definitions

491

1561

1.89

34.53

1.3

4.90

4.83

umol/l

0.14

443

1443

Other antidepressants

496

1369

1.90

34.30

1.3

1.2

4.99

5.35

umol/l

1.16

453

1280

Personality disorders, excluding more controls

197

773

2.57

33.17

1.5

1.2

4.97

5.89

umol/l

2.82

179

730

Episodal and paroxysmal disorders

603

1783

1.74

31.51

1.4

1.2

5.23

5.34

umol/l

0.26

547

1668

Other endocrine disorders

140

4.94

31.42

1.6

1.5

3.43

5.13

umol/l

3.39

125

General symptoms and signs

581

1665

1.75

31.14

1.4

1.2

5.03

5.36

umol/l

0.86

529

1539

Pain in joint

311

974

2.12

31.13

1.4

1.2

4.82

5.51

umol/l

2.30

276

909

Exclusions for E4_PCOS_CONSORTIUM

469

1608

1.84

30.76

1.5

1.3

4.69

5.37

umol/l

3.15

433

1482

Hypothyroidism, strict autoimmune, 3 medication purchases required

441

1637

1.84

29.91

1.4

1.2

4.99

5.26

umol/l

0.51

401

1515

Migraine

354

1566

1.93

28.92

1.5

1.2

5.28

5.66

umol/l

1.08

322

1467

Other disorders of fluid, electrolyte and acid-base balance

102

288

3.43

28.73

1.6

1.3

3.08

3.61

umol/l

0.80

266

Procreative management

228

852

2.27

28.43

1.5

1.3

5.25

5.36

umol/l

0.15

208

779

Somatoform disorder

106

333

3.21

27.03

1.6

1.2

4.45

5.28

umol/l

1.39

314

Sleep apnoea, including avohilmo

354

1205

1.91

26.64

1.3

4.32

4.25

umol/l

0.08

305

1119

Sleep apnoea

318

1094

1.98

26.63

1.3

4.24

4.05

umol/l

0.23

274

1011

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

135

4.66

26.62

1.3

1.4

4.04

4.34

umol/l

0.20

127

Non-invasive ventilation

105

313

3.17

25.90

1.3

2.56

5.04

umol/l

12.42

295

Benign neoplasms

523

1725

1.70

25.81

1.3

4.57

5.78

umol/l

10.38

488

1595

Autoimmune diseases

571

1764

1.66

25.27

1.4

1.2

4.88

5.43

umol/l

2.68

521

1642

GASTRO-related operations

503

1476

1.72

25.12

1.5

1.2

5.19

5.76

umol/l

2.53

464

1378

Any gastric operation

503

1476

1.72

25.12

1.5

1.2

5.19

5.76

umol/l

2.53

464

1378

Sleep disorders (combined)

409

1523

1.76

24.02

1.3

4.51

4.87

umol/l

0.65

353

1415

Symptoms and signs involving the digestive system and abdomen

485

1433

1.70

23.54

1.3

1.2

4.85

5.29

umol/l

1.67

439

1326

Abdominal and pelvic pain

481

1432

1.69

23.01

1.4

1.2

4.81

5.29

umol/l

1.93

442

1325

Other metabolic disorders

251

3.34

22.60

1.5

1.4

4.18

4.73

umol/l

0.63

233

Disorders of adult personality and behaviour

212

1018

2.10

22.49

1.4

1.3

5.18

6.02

umol/l

2.63

191

955

Triptan medication for migraine, single purchase ok

444

1786

1.69

22.48

1.4

1.2

5.36

5.43

umol/l

0.15

408

1661

Migraine, single triptan purchase ok & required. ICD-code if available is included

444

1786

1.69

22.48

1.4

1.2

5.36

5.43

umol/l

0.15

408

1661

Parasetamol

449

1343

1.71

22.43

1.3

1.2

5.64

5.70

umol/l

0.13

414

1262

Benign neoplasms

468

1582

1.68

22.35

1.4

1.2

4.80

5.98

umol/l

8.95

437

1466

Postprocedural endocrine and metabolic disorders, not elsewhere classified

223

3.44

21.71

1.6

1.3

4.33

4.76

umol/l

0.42

206

Personality disorders

197

936

2.12

21.52

1.5

1.3

4.97

5.96

umol/l

3.28

179

876

Neurological diseases

495

1517

1.65

21.45

1.4

1.3

5.39

5.53

umol/l

0.33

449

1433

Endometriosis

179

465

2.30

21.34

1.3

1.2

4.70

4.99

umol/l

0.41

168

422

L02BG Aromatase inhibitors

107

392

2.75

20.84

1.2

1.3

4.96

3.47

umol/l

3.33

100

358

Dermatitis and eczema

505

2080

1.60

20.45

1.3

4.72

5.22

umol/l

2.23

464

1920

Persons encountering health services for other counselling and medical advice, not elsewhere classified

506

1816

1.59

19.77

1.4

1.3

4.76

5.19

umol/l

1.68

462

1677

Other headache syndromes

216

1097

1.98

19.66

1.3

1.2

4.15

5.25

umol/l

4.93

194

1023

Specific personality disorders

175

831

2.12

19.22

1.4

1.3

5.15

6.02

umol/l

2.40

155

780

Neurological diseases, wide definition

241

611

1.99

19.18

1.4

1.3

5.72

6.15

umol/l

0.83

219

577

Malaise and fatigue

199

821

2.03

18.84

1.6

1.2

4.29

4.96

umol/l

1.69

185

759

Neoplasms

472

1583

1.60

18.71

1.4

1.2

5.16

5.98

umol/l

5.14

445

1464

Type 2 diabetes, wide definition

215

706

1.99

18.39

1.3

3.80

3.72

umol/l

0.09

193

649

Obesity related asthma

139

618

2.26

17.98

1.4

1.3

4.33

4.55

umol/l

0.28

121

568

Malignant neoplasm of endocrine gland

113

4.21

17.91

1.4

3.95

4.25

umol/l

0.19

106

Antihypertensive medication - note that there are other indications

442

1526

1.59

17.08

1.4

1.3

5.50

5.97

umol/l

1.76

407

1430

Symptoms and signs involving the circulatory and respiratory systems

533

1752

1.53

17.05

1.4

1.3

4.93

5.47

umol/l

2.60

489

1635

Hypothyroidism, drug reimbursement

197

2.96

16.70

1.7

1.1

4.62

5.67

umol/l

1.67

183

Other reaction to severe stress, and adjustment disorders

219

1185

1.86

16.58

1.4

1.3

5.15

5.54

umol/l

0.83

202

1096

Fibromyalgia

191

3.28

16.52

1.5

1.2

3.35

5.03

umol/l

3.40

177

Metabolic disorders

328

1212

1.68

16.41

1.4

1.3

3.66

4.51

umol/l

3.77

300

1105

Benzodiazepine use

417

1893

1.57

16.21

1.4

1.2

4.73

5.08

umol/l

1.09

383

1744

Hypo-osmolality and hyponatraemia

138

3.63

15.65

1.8

1.4

3.12

3.32

umol/l

0.12

126

Gastrointestinal diseases

384

1198

1.61

15.42

1.3

5.22

5.94

umol/l

3.33

354

1124

Schizophrenia or delusion, excluding more controls

136

637

2.13

15.22

1.2

5.46

5.41

umol/l

0.05

123

601

Persons encountering health services in other circumstances, wide

522

1817

1.49

15.19

1.4

1.3

4.79

5.19

umol/l

1.47

475

1678

Persons encountering health services for examination and investigation

276

791

1.75

15.18

1.4

1.2

5.08

5.46

umol/l

0.80

258

744

Generalized anxiety disorder

131

616

2.15

14.91

1.2

5.96

6.26

umol/l

0.42

124

576

Myalgia

123

564

2.19

14.87

1.6

1.2

4.20

5.41

umol/l

3.46

110

523

Nausea and vomiting

131

606

2.14

14.80

1.5

1.3

4.49

5.36

umol/l

1.59

117

566

Other functional intestinal disorders

186

942

1.89

14.78

1.5

1.3

4.10

4.92

umol/l

2.36

174

862

Behavioural syndromes associated with physiological disturbances and physical factors

228

1298

1.77

14.66

1.4

1.3

5.17

5.89

umol/l

2.23

206

1211

Acute upper respiratory infections

459

1911

1.51

14.55

1.3

5.35

5.04

umol/l

0.62

413

1770

Disorders of puberty, other/unspecified

13.97

14.46

1.8

1.1

5.74

6.30

umol/l

0.13

Temporomandibular joint disorders

385

2.43

14.29

1.7

1.2

3.73

5.89

umol/l

6.85

361

Menorrhagia

144

375

2.13

14.28

1.5

1.2

4.98

4.21

umol/l

1.69

131

341

Other diseases of hard tissues of teeth

275

1223

1.68

14.22

1.3

4.52

4.97

umol/l

1.26

254

1133

Dorsopathies

514

1779

1.48

14.19

1.3

1.2

5.16

5.53

umol/l

1.33

477

1646

Certain infectious and parasitic diseases

489

1648

1.49

13.97

1.3

5.04

5.32

umol/l

0.87

448

1532

Pain (limb, back, neck, head abdominally)

329

1013

1.63

13.95

1.3

1.2

5.17

5.42

umol/l

0.54

305

941

Hypertension, essential

249

817

1.74

13.90

1.4

1.3

4.10

4.24

umol/l

0.13

233

752

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

168

886

1.91

13.88

1.3

1.2

5.01

5.85

umol/l

1.98

145

828

Care involving use of rehabilitation procedures

244

1362

1.71

13.87

1.5

1.3

3.79

4.73

umol/l

3.73

218

1260

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

290

2.63

13.83

1.3

3.26

3.81

umol/l

0.68

266

Migraine without aura

163

853

1.93

13.83

1.8

1.3

5.36

5.95

umol/l

1.02

144

789

Acne

108

486

2.25

13.77

1.1

1.2

6.79

6.31

umol/l

0.60

453

Chronic diseases of tonsils and adenoids

401

1661

1.53

13.74

1.4

1.3

5.27

5.25

umol/l

0.03

370

1537

Other dorsopathies, not elsewhere classified

487

1739

1.48

13.69

1.3

1.2

5.07

5.57

umol/l

1.95

447

1610

Ovarian cyst

174

520

1.94

13.67

1.3

1.2

4.73

5.20

umol/l

0.86

162

473

Non-selective monoamine reuptake inhibitors

104

447

2.26

13.60

1.5

1.2

2.92

3.77

umol/l

1.76

411

Tonsillectomy and adenotomy

377

1709

1.54

13.53

1.3

5.95

5.51

umol/l

1.40

348

1578

Opioids

478

1698

1.48

13.47

1.4

1.2

4.81

5.63

umol/l

4.78

433

1586

Post-traumatic stress disorder

367

2.43

13.41

1.5

1.2

5.47

6.37

umol/l

1.50

344

Other specified and unspecified personality disorders

217

2.89

13.36

1.5

1.2

4.93

5.46

umol/l

0.57

206

Benign neoplasm of other and ill-defined parts of digestive system

180

3.02

12.67

1.4

1.3

3.04

3.68

umol/l

0.82

171

Sciatica+with lumbago

182

961

1.80

12.62

1.7

1.2

4.71

4.82

umol/l

0.08

167

886

Dorsalgia

467

1730

1.46

12.58

1.3

1.2

5.12

5.57

umol/l

1.04

424

1602

Abnormal findings on examination of blood, without diagnosis

130

608

2.01

12.44

1.4

1.3

3.74

4.28

umol/l

1.00

117

559

Gestational diabetes (for exclusion)

303

1358

1.59

12.38

1.2

1.3

6.07

5.74

umol/l

0.79

286

1257

Implicit viral Sepsis

278

2.57

12.33

1.5

1.4

3.44

4.84

umol/l

3.32

259

Hypertensive diseases (excluding secondary)

223

750

1.73

12.32

1.5

1.3

3.99

4.76

umol/l

2.39

208

685

Dentinal caries

106

493

2.15

12.29

1.5

1.3

3.94

5.14

umol/l

3.07

454

Dental caries 2 and operation codes

376

1995

1.50

12.26

1.2

1.3

5.69

5.22

umol/l

1.64

344

1846

Viral Sepsis

279

2.56

12.24

1.5

1.4

3.44

4.83

umol/l

3.28

260

Nonorganic sleeping disorders, excluding more controls

104

484

2.16

12.22

1.4

1.3

5.04

5.81

umol/l

1.14

457

Other diseases of upper respiratory tract

476

1716

1.45

12.06

1.3

5.00

5.15

umol/l

0.35

433

1586

Polyuria

252

2.63

12.06

1.7

1.2

3.61

4.35

umol/l

0.93

237

Irritable bowel syndrome

135

696

1.95

12.01

1.4

1.2

4.27

5.40

umol/l

3.70

123

650

Acute upper respiratory infections of multiple and unspecified sites

354

1755

1.51

11.97

1.3

5.54

5.31

umol/l

0.33

323

1629

Bronchitis

460

2094

1.44

11.94

1.3

5.43

5.10

umol/l

0.66

419

1939

Symptoms and signs involving the nervous and musculoskeletal systems

222

1330

1.67

11.93

1.5

1.3

3.90

5.02

umol/l

4.69

205

1218

Endometriosis of pelvic peritoneum

303

2.46

11.85

1.2

4.36

4.70

umol/l

0.31

277

Dental caries

118

577

2.03

11.85

1.6

1.3

3.85

5.19

umol/l

4.08

103

533

Other menopausal disorders

225

2.37

11.82

1.7

1.2

3.36

2.95

umol/l

0.79

207

Diseases of the ear and mastoid process

537

1927

1.41

11.80

1.4

1.2

4.92

5.28

umol/l

1.37

490

1785

Medicines for HER+ breast cancer

120

581

2.02

11.79

1.2

1.4

4.86

3.56

umol/l

3.32

111

526

Hypertension

264

917

1.63

11.67

1.5

1.3

3.84

4.26

umol/l

1.14

246

840

Dental caries 2, only avohilmo

375

1998

1.48

11.59

1.3

5.74

5.21

umol/l

1.97

342

1851

Hypertensive diseases

264

920

1.63

11.54

1.5

1.3

3.84

4.26

umol/l

1.15

246

843

Dental caries 2

375

1994

1.48

11.48

1.2

1.3

5.70

5.20

umol/l

1.79

342

1846

Polyp of the female genital tract

111

303

2.14

11.37

1.3

1.2

4.85

3.73

umol/l

0.73

103

276

Abnormalities of heart beat

143

760

1.87

11.30

1.4

1.2

4.92

5.37

umol/l

0.71

119

710

Persistent mood disorders

396

2.23

11.27

1.2

4.22

5.35

umol/l

2.48

372

Dentofacial anomalies [including malocclusion]

158

869

1.81

11.13

1.6

1.3

3.84

5.45

umol/l

7.00

138

807

Symptoms and signs involving the skin and subcutaneous tissue

267

1697

1.57

11.11

1.4

1.3

4.24

5.00

umol/l

2.86

240

1560

Cystitis

421

1781

1.45

11.03

1.3

1.2

5.12

5.35

umol/l

0.62

388

1648

Oedema, not elsewhere classified

457

2.12

10.91

1.5

1.2

4.41

4.44

umol/l

0.03

423

Other problems related to primary support group, including family circumstances

109

528

2.03

10.83

1.6

1.3

5.12

5.67

umol/l

0.74

493

Benign neoplasm of other and ill-defined parts of digestive system

197

2.75

10.82

1.4

1.3

3.04

3.74

umol/l

0.91

182

Asthma (mode)

332

1212

1.51

10.43

1.4

1.2

4.24

5.20

umol/l

5.07

301

1133

Anaemias

121

410

1.97

10.36

1.4

1.2

3.85

5.85

umol/l

8.99

114

387

Panic disorder

113

579

1.97

10.35

1.3

1.2

5.47

6.23

umol/l

1.38

105

543

Asthma

336

1202

1.50

10.35

1.4

1.2

4.22

5.19

umol/l

5.15

304

1126

Emotionally unstable personality disorder

109

552

1.99

10.34

1.4

1.2

5.45

6.23

umol/l

1.27

519

Other pulmonary diagnosis

358

1209

1.49

10.31

1.3

1.2

5.06

5.20

umol/l

0.26

322

1132

Low back pain

309

1584

1.51

10.29

1.4

1.2

4.95

5.45

umol/l

0.79

281

1469

Soft tissue disorders

499

1864

1.39

10.26

1.4

1.3

4.85

5.57

umol/l

4.15

461

1726

First line medication for Crohn's disease

495

1943

1.39

10.24

1.5

1.2

3.96

5.53

umol/l

17.57

442

1805

KRA_PSY_EATING, excluding more controls

485

2.06

10.23

1.2

5.90

6.54

umol/l

1.17

461

Other disorders of lacrimal gland

121

637

1.91

10.19

1.6

1.3

4.05

4.58

umol/l

0.85

110

592

Excluding asthma or asthma-COPD overlap

357

1209

1.48

10.15

1.3

1.2

5.03

5.20

umol/l

0.34

321

1132

Asthma, excluding more controls

334

1193

1.50

10.06

1.4

1.2

4.24

5.20

umol/l

5.04

302

1117

Spondylosis

121

545

1.91

9.99

1.6

1.2

2.76

3.48

umol/l

2.10

107

499

Dysplasia of cervi uteri

106

409

2.01

9.97

1.4

1.2

6.15

5.05

umol/l

2.12

375

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

164

881

1.73

9.94

1.4

1.3

3.39

3.94

umol/l

1.12

147

805

Other/unspecified dorsalgia

145

811

1.78

9.91

1.4

1.2

4.49

5.20

umol/l

1.29

133

752

Diseases of the eye and adnexa

453

1616

1.41

9.81

1.3

5.54

5.52

umol/l

0.04

419

1498

Chronic periapical parodontitis

292

2.34

9.77

1.4

1.2

3.98

4.65

umol/l

0.84

266

ILD differential diagnosis

355

1212

1.47

9.72

1.3

1.2

5.03

5.20

umol/l

0.33

320

1133

Other diseases of urinary system

460

1860

1.39

9.69

1.4

1.2

4.98

5.27

umol/l

0.91

425

1721

Abnormalities of breathing

416

1749

1.42

9.68

1.4

1.3

4.44

5.47

umol/l

3.51

374

1632

COPD differential diagnosis

355

1213

1.47

9.68

1.3

1.2

5.03

5.19

umol/l

0.32

320

1134

Inflammatory diseases of female pelvic organs

343

1784

1.45

9.56

1.4

1.3

4.62

5.53

umol/l

4.89

313

1653

Acne vulgaris

366

2.18

9.55

1.2

1.1

7.09

6.36

umol/l

0.82

339

Supervision of high-risk pregnancy

189

686

1.68

9.43

1.3

5.82

5.96

umol/l

0.22

181

631

Asthma (only as main-diagnosis)

298

1202

1.50

9.35

1.4

1.2

4.27

5.19

umol/l

4.59

272

1126

Coxibs

137

395

1.85

9.35

1.3

1.2

5.36

5.97

umol/l

0.90

128

371

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

130

722

1.81

9.34

1.3

1.2

5.16

6.00

umol/l

2.04

120

670

Diseases of middle ear and mastoid

319

1793

1.46

9.30

1.4

1.2

5.64

5.67

umol/l

0.05

295

1664

Cervicalgia

325

2.22

9.23

1.2

3.19

4.69

umol/l

4.14

303

Missing teeth due to accident, extraction or parodontitis

110

3.20

9.16

1.7

1.2

2.20

3.94

umol/l

3.22

100

Asthma (only as main-diagnosis), excluding more controls

298

1193

1.49

9.12

1.4

1.2

4.27

5.20

umol/l

4.67

272

1117

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

192

1084

1.62

9.10

1.3

6.33

6.27

umol/l

0.06

177

1014

Other diseases of intestines

468

1986

1.37

9.06

1.3

4.29

5.35

umol/l

7.94

426

1837

Disorders of lacrimal system

142

816

1.75

9.05

1.5

1.3

4.22

4.67

umol/l

0.72

130

752

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

303

1251

1.48

9.04

1.3

3.91

4.49

umol/l

1.70

270

1153

Intestinal infectious diseases

393

2189

1.40

9.01

1.5

1.3

4.88

5.24

umol/l

1.13

355

2029

Abnormal findings on diagnostic imaging of other body structures

165

2.74

9.00

1.2

1.3

3.31

4.25

umol/l

0.94

154

Any reimbursement code in KELA

376

1320

1.43

8.99

1.4

1.2

5.37

6.09

umol/l

2.89

347

1231

Kela-code for severe mental illness

156

923

1.70

8.96

1.2

1.3

5.43

5.32

umol/l

0.12

145

857

Other noninflammatory disorders of uterus, except cervix

183

2.39

8.95

1.4

1.2

4.12

2.88

umol/l

1.86

170

Other symptoms and signs involving the digestive system and abdomen

285

2.29

8.95

1.3

4.36

4.38

umol/l

0.01

267

Diabetes mellitus in pregnancy

280

1217

1.50

8.90

1.3

1.2

6.33

5.90

umol/l

1.09

265

1127

Phobic anxiety disorders

100

519

1.94

8.88

1.5

1.2

5.39

6.34

umol/l

1.58

490

Schizophrenia, schizotypal and delusional disorders

137

784

1.75

8.88

1.2

1.3

5.42

5.43

umol/l

0.01

124

729

474

1833

1.37

8.85

1.4

1.3

5.20

5.07

umol/l

0.21

430

1696

Pulmonary heart disease, diseases of pulmonary circulation

338

2.16

8.79

1.3

1.2

3.47

3.83

umol/l

0.41

313

Lower back pain or/and sciatica

405

2024

1.39

8.78

1.4

1.2

4.78

5.21

umol/l

0.85

368

1879

Migraine without aura and triptan purchases

126

707

1.80

8.78

1.7

1.3

5.05

5.97

umol/l

1.70

108

659

Implicit Sepsis

226

1136

1.55

8.70

1.5

1.3

3.76

4.67

umol/l

3.66

202

1047

Schizophrenia or delusion

136

782

1.75

8.68

1.2

1.3

5.46

umol/l

0.01

123

727

Mycoses

509

1.93

8.67

1.3

3.99

4.87

umol/l

1.66

469

Pulmonary embolism

302

2.22

8.63

1.3

1.2

3.53

3.75

umol/l

0.21

282

Pulmonary heart disease

302

2.22

8.63

1.3

1.2

3.53

3.75

umol/l

0.21

282

Follow-up examination after treatment for conditions other than malignant neoplasms

173

684

1.66

8.59

1.3

1.2

4.65

5.49

umol/l

2.47

160

645

Pruritus

225

2.42

8.38

1.6

1.3

5.17

5.14

umol/l

0.02

210

Soft tissue disorders related to use, overuse and pressure

352

2.11

8.36

1.5

1.2

2.93

4.15

umol/l

3.30

329

Dizziness and giddiness

247

1336

1.50

8.36

1.4

1.2

4.19

4.79

umol/l

1.90

225

1225

Pure hypercholesterolaemia

149

585

1.71

8.33

1.2

1.3

2.88

3.41

umol/l

1.07

133

538

Codeine

410

1634

1.38

8.24

1.3

1.2

4.48

5.57

umol/l

6.80

373

1525

Osteoporosis

221

2.38

8.23

1.7

1.3

2.17

3.14

umol/l

1.98

205

Unspecified mental disorder

178

1119

1.60

8.10

1.3

5.35

5.42

umol/l

0.08

165

1031

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

170

1038

1.61

7.97

1.3

1.2

4.50

4.87

umol/l

0.63

151

960

Gastro-oesophageal reflux disease

211

1221

1.53

7.97

1.2

1.3

4.05

4.58

umol/l

1.22

187

1127

Tramadol

249

1073

1.49

7.90

1.5

1.2

3.91

4.80

umol/l

1.41

217

998

Anomalies of dental arch relationship, including avohilmo

135

714

1.71

7.86

1.6

1.3

5.56

5.94

umol/l

0.51

116

663

Glucagon-like peptide-1 (GLP-1) analogues

417

1.90

7.85

1.1

1.3

3.23

3.08

umol/l

0.13

383

Infections of the skin and subcutaneous tissue

230

1537

1.49

7.79

1.4

1.3

4.75

5.24

umol/l

1.31

217

1411

Codeine or tramadol medication

452

1863

1.35

7.76

1.3

1.2

4.27

5.40

umol/l

7.85

409

1728

Spinal stenosis

365

1.94

7.74

1.3

1.2

1.86

3.12

umol/l

7.03

334

Other symptoms and signs involving cognitive functions and awareness

102

522

1.84

7.72

1.5

1.2

3.77

4.03

umol/l

0.36

479

Other soft tissue disorders, not elsewhere classified

404

1834

1.36

7.69

1.5

1.2

4.27

5.58

umol/l

10.64

372

1697

Complications of procedures, not elsewhere classified

273

1636

1.44

7.67

1.4

1.3

3.64

4.92

umol/l

7.91

250

1502

Other symptoms and signs involving the nervous and musculoskeletal systems

163

1018

1.61

7.65

1.5

1.3

3.81

5.00

umol/l

3.94

152

937

Diseases of the musculoskeletal system and connective tissue

330

1170

1.42

7.62

1.3

5.77

5.86

umol/l

0.16

306

1086

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

185

1187

1.56

7.60

1.4

1.2

3.48

4.71

umol/l

5.16

169

1086

Cervicocranial syndrome

157

2.63

7.60

1.4

1.2

3.63

4.80

umol/l

1.04

148

Sleep disorders

112

635

1.77

7.59

1.4

1.3

5.10

5.70

umol/l

0.84

100

590

Substance abuse, excluding more controls

173

958

1.58

7.53

1.1

1.2

4.81

5.31

umol/l

0.89

154

894

Condition for Implicit Sepsis (Organ dysfunction codes)

281

1423

1.44

7.49

1.4

1.3

3.84

4.96

umol/l

6.29

255

1308

Other sleep disorders

170

2.54

7.48

1.3

1.2

4.52

5.19

umol/l

0.45

163

Disorders of tooth development and eruption

201

2.40

7.45

1.7

1.4

3.83

5.40

umol/l

2.49

186

Correction of physiology of bite - demanding therapy visit

171

2.54

7.42

2.0

1.2

4.10

5.37

umol/l

1.49

162

Diseases of oral cavity, salivary glands and jaws

339

1242

1.40

7.41

1.3

4.70

4.95

umol/l

0.59

313

1150

DVT of lower extremities and pulmonary embolism

465

1.89

7.38

1.3

1.2

3.67

3.76

umol/l

0.08

426

Vasomotor and allergic rhinitis

202

1318

1.52

7.34

1.3

4.80

5.56

umol/l

2.12

188

1220

Atopic dermatitis

298

1808

1.41

7.32

1.4

1.3

5.17

5.63

umol/l

1.38

278

1679

Diabetes insipidus

16.20

7.28

2.6

1.0

2.42

5.70

umol/l

—

Oxycodone

339

2.03

7.28

2.0

1.2

2.67

3.83

umol/l

2.62

314

Vocal cord dysfunction

182

2.41

7.21

1.4

1.2

4.06

4.70

umol/l

0.56

173

Nontoxic goitre/thyroid nodule

422

1.93

7.18

1.3

3.20

3.75

umol/l

0.94

389

Fever of other and unknown origin

200

1229

1.51

7.17

1.3

1.2

4.60

5.34

umol/l

2.38

188

1136

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

174

1121

1.55

7.16

1.4

1.3

3.43

4.70

umol/l

5.11

158

1029

Complications of medical and surgical care

233

1514

1.46

7.15

1.4

1.2

3.50

4.81

umol/l

6.97

214

1388

Diabetes, insulin treatment (Kela reimbursement)

312

1363

1.40

7.08

1.3

3.85

4.49

umol/l

2.15

279

1256

Diverticular disease of intestine

142

571

1.65

7.07

1.3

1.2

2.81

3.22

umol/l

0.79

127

524

Substance use, excluding alcohol

439

1.90

7.05

1.2

5.16

5.43

umol/l

0.21

416

Social phobias

303

2.10

7.02

1.4

1.2

5.41

6.43

umol/l

1.12

288

Candidiasis

270

2.16

7.01

1.3

4.56

5.09

umol/l

0.51

251

Diseases of pulp and periapical tissues

116

682

1.71

6.94

1.3

4.20

5.04

umol/l

1.60

105

630

Dysphagia

271

2.15

6.93

1.2

3.87

4.28

umol/l

0.36

254

Conjunctivitis

339

2168

1.37

6.93

1.3

4.73

5.32

umol/l

2.60

310

2003

Triptan medication for migraine, min. 3 purchases

314

1793

1.39

6.92

1.4

1.2

5.06

5.63

umol/l

2.21

281

1677

Use of hypnotics and sedatives

355

1502

1.37

6.91

1.4

1.3

4.01

4.75

umol/l

3.50

326

1377

Deposits [accretions] on teeth

165

2.48

6.88

1.4

1.6

3.43

3.93

umol/l

0.50

151

Symptoms and signs involving cognition, perception, emotional state and behaviour

343

1761

1.37

6.86

1.5

1.2

4.39

4.99

umol/l

2.47

315

1620

Symptoms and signs involving speech and voice

100

566

1.77

6.84

1.6

1.4

4.76

4.26

umol/l

0.23

526

Other disorders of teeth and supporting structures

320

2.04

6.79

1.5

1.2

4.14

4.72

umol/l

0.54

293

Other and unspecified nonorganic psychotic disorders

546

1.78

6.78

1.2

5.83

5.81

umol/l

0.02

508

Cutaneous abscess, furuncle and carbuncle

103

591

1.75

6.74

1.4

1.2

4.95

5.22

umol/l

0.29

547

Other specific joint derangements/joint disorders

355

1757

1.36

6.74

1.4

1.2

4.64

5.69

umol/l

5.72

318

1642

Nonorganic sleeping disorders

104

599

1.75

6.73

1.4

1.3

5.04

5.75

umol/l

1.03

555

Spondylopathies

203

820

1.51

6.70

1.5

1.2

2.89

4.36

umol/l

8.87

179

754

Disorders of conjunctiva

354

2201

1.35

6.69

1.3

4.72

5.28

umol/l

2.40

325

2034

Insomnia

442

1.87

6.61

1.5

1.3

5.07

5.62

umol/l

0.57

413

Temporomandibular joint disorders, including avohilmo

238

1664

1.43

6.59

1.6

1.2

4.84

5.82

umol/l

4.68

216

1543

Dyspnoea

301

1670

1.38

6.57

1.4

1.3

4.23

4.91

umol/l

1.26

272

1532

Other neurological diseases

187

998

1.51

6.56

1.4

1.2

3.48

4.24

umol/l

2.62

170

914

Erosion of teeth, including avohilmo

104

584

1.73

6.49

1.2

4.78

5.49

umol/l

1.26

543

Suicide or other Intentional self-harm

120

727

1.66

6.46

1.3

4.87

5.68

umol/l

1.43

680

Mouth breathing

126

773

1.63

6.42

1.4

4.33

4.17

umol/l

0.08

108

714

Pain associated with micturition

209

2.26

6.38

1.3

4.85

4.74

umol/l

0.05

196

Nerve, nerve root and plexus disorders

347

1620

1.35

6.27

1.4

1.2

3.91

4.90

umol/l

5.73

305

1500

Hyperkinetic disorders, excluding more controls

474

1.80

6.23

1.3

1.4

6.27

6.21

umol/l

0.05

447

Bipolar affective disorders

554

1.74

6.20

1.2

5.10

5.90

umol/l

1.32

526

Acetic acid derivatives and related substances

123

383

1.68

6.17

1.2

5.81

5.93

umol/l

0.11

110

359

Rheumatism, unspecified

187

2.31

6.15

1.6

1.2

3.26

4.07

umol/l

0.75

175

Syncope and collapse

138

773

1.58

6.15

1.3

1.2

4.14

5.12

umol/l

2.99

123

719

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

178

585

1.53

6.10

1.3

1.2

5.55

5.92

umol/l

0.54

167

554

Autoimmune diseases related-to ILD

311

2025

1.35

6.08

1.4

1.3

4.09

5.11

umol/l

5.74

287

1864

Disturbances of skin sensation

121

747

1.63

6.08

1.5

1.2

4.10

5.36

umol/l

3.65

108

698

Visual disturbances and blindness

176

1184

1.49

6.03

1.4

1.3

4.82

4.93

umol/l

0.15

163

1088

Diseases of the respiratory system

288

1041

1.39

6.02

1.3

1.2

4.99

5.29

umol/l

0.67

263

974

Gingivitis and periodontal diseases

321

1221

1.36

5.94

1.3

4.75

5.00

umol/l

0.57

295

1130

Disorders of refraction and accommodation

149

968

1.54

5.93

1.3

5.42

5.47

umol/l

0.05

143

887

Visual disturbances

166

1108

1.50

5.92

1.4

1.3

4.88

4.94

umol/l

0.07

154

1018

Direct fill therapy

317

1.97

5.90

1.5

4.07

4.99

umol/l

1.37

294

Complications of surgical and medical care, not elsewhere classified

330

1770

1.34

5.87

1.3

3.71

5.02

umol/l

9.41

304

1628

Lumbar disc prolapse

185

999

1.47

5.84

1.3

1.2

3.68

4.72

umol/l

3.85

168

921

Symptoms and signs involving the urinary system

221

1200

1.43

5.83

1.4

1.3

3.77

4.68

umol/l

3.06

200

1100

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

168

1129

1.49

5.82

1.3

5.01

5.90

umol/l

2.24

145

1054

Asthma, unspecified (mode)

180

965

1.48

5.82

1.4

1.2

3.62

5.01

umol/l

6.49

160

908

Voice disturbances

461

1.78

5.82

1.6

1.4

3.83

4.24

umol/l

0.53

432

Implicit bacterial Sepsis

368

1.85

5.80

1.3

1.2

3.38

3.65

umol/l

0.27

336

Pain in throat and chest

313

1417

1.35

5.79

1.3

1.2

3.92

5.25

umol/l

8.96

290

1317

Pregnancy examination and test

158

647

1.53

5.72

1.2

1.3

6.26

6.28

umol/l

0.02

148

595

Asthma, unspecified (mode), excluding more controls

180

959

1.48

5.72

1.4

1.2

3.62

5.02

umol/l

6.58

160

902

Other intervertebral disc disorders

261

1152

1.39

5.71

1.5

1.2

4.05

4.88

umol/l

1.34

232

1060

Disorders of lipoprotein metabolism and other lipidaemias

164

682

1.51

5.67

1.3

3.10

3.55

umol/l

0.85

145

620

Migraine with aura

142

927

1.54

5.65

1.4

1.2

5.53

5.86

umol/l

0.49

129

864

Persons encountering health services in circumstances related to reproduction

241

1168

1.40

5.65

1.4

1.3

5.28

5.24

umol/l

0.05

222

1066

Cough

146

919

1.53

5.64

1.4

1.3

4.32

5.11

umol/l

1.93

133

855

Diarrhoea and gastroenteritis of presumed infectious origin

283

1902

1.35

5.63

1.5

1.3

4.64

5.37

umol/l

3.00

255

1758

Cholelithiasis

245

1234

1.39

5.63

1.3

4.03

4.40

umol/l

0.42

225

1135

190

1306

1.45

5.62

1.5

1.3

4.44

5.48

umol/l

3.71

178

1214

Impingement syndrome of shoulder

281

2.00

5.62

1.4

1.2

2.81

3.53

umol/l

1.33

259

Deforming dorsopathies

106

649

1.64

5.54

1.4

1.3

4.26

5.25

umol/l

2.25

602

COPD/asthma related infections

434

1689

1.29

5.53

1.3

1.2

5.22

5.12

umol/l

0.15

397

1565

COPD/asthma/ILD related infections

434

1689

1.29

5.53

1.3

1.2

5.22

5.12

umol/l

0.15

397

1565

Shoulder lesions

196

827

1.45

5.53

1.3

1.2

3.13

4.39

umol/l

6.05

177

758

Persons encountering health services in other circumstances

164

1110

1.48

5.48

1.4

1.3

4.95

5.60

umol/l

1.47

151

1031

External causes of morbidity and mortality

336

1265

1.33

5.48

1.4

1.3

5.20

5.42

umol/l

0.42

311

1184

Poisoning by medicine

115

722

1.60

5.45

1.2

1.3

5.01

5.90

umol/l

1.64

100

678

Paralytic ileus and intestinal obstruction

238

2.06

5.38

1.5

1.2

2.66

3.61

umol/l

1.66

223

Constipation

267

1405

1.36

5.38

1.5

1.3

3.54

4.53

umol/l

5.11

240

1290

Chronic laryngitis and laryngotracheitis

175

2.24

5.24

1.2

2.66

4.03

umol/l

2.07

164

Other and unspecified mood [affective] disorders

248

2.03

5.24

1.4

1.2

6.30

6.28

umol/l

0.01

240

Other and unspecified medical devices associated with adverse incidents

+∞

5.23

2.2

0.0

3.36

—

umol/l

—

Osteopathies and chondropathies

165

1071

1.46

5.21

1.6

1.3

3.56

4.78

umol/l

4.79

144

987

Dental pulpitis 4, only avohilmo

459

1894

1.27

5.19

1.3

5.13

5.32

umol/l

0.45

425

1752

Postpartum hemorraghe, parous women as controls

153

903

1.49

5.18

1.3

5.87

5.45

umol/l

0.87

148

836

Trochanteric bursitis

170

2.24

5.15

1.7

1.2

2.56

4.05

umol/l

2.82

158

Diseases of arteries, arterioles and capillaries (FINNGEN)

165

2.08

5.14

1.1

1.2

2.54

3.87

umol/l

2.17

152

Type 1 diabetes

101

623

1.62

5.13

1.7

1.4

4.49

5.18

umol/l

1.23

576

Dental pulpitis 4

455

1869

1.27

5.13

1.3

5.13

5.33

umol/l

0.49

418

1729

Cholecystectomy

194

1212

1.42

5.11

1.4

1.3

4.02

4.25

umol/l

0.19

172

1114

Benign neoplasm of colon, rectum, anus and anal canal

110

624

1.59

5.11

1.2

1.3

3.15

3.29

umol/l

0.17

102

572

Cardiovascular diseases

386

1634

1.29

5.07

1.4

1.3

5.05

5.97

umol/l

5.63

358

1518

Dental pulpitis 1

454

1869

1.26

5.04

1.3

5.13

5.33

umol/l

0.50

418

1728

Allergic rhinitis

179

1243

1.43

5.04

1.3

4.92

5.74

umol/l

2.28

167

1151

Asthma, including avohilmo

466

2158

1.26

5.03

1.4

1.3

4.40

5.32

umol/l

6.16

420

1999

Other maternal disorders predominantly related to pregnancy

318

1521

1.32

5.03

1.3

5.50

5.47

umol/l

0.04

300

1407

Other systemic involvement of connective tissue (FG)

487

1.70

5.01

1.4

1.3

4.00

4.79

umol/l

1.28

455

Dental pulpitis 1, only avohilmo

458

1899

1.26

5.00

1.3

5.14

5.31

umol/l

0.42

425

1756

Disorders of psychological development

554

1.63

4.96

1.4

1.3

6.29

6.16

umol/l

0.12

514

Other abnormal uterine and vaginal bleeding

246

1.86

4.96

1.7

1.2

4.69

3.99

umol/l

0.79

228

Superficial injury of abdomen, lower back and pelvis

382

1.79

4.91

1.5

1.2

4.81

5.63

umol/l

1.05

352

Insulin medication

159

933

1.46

4.91

1.4

1.3

4.21

4.63

umol/l

0.69

138

866

Eating disorder

617

1.62

4.90

1.2

5.90

6.53

umol/l

1.16

575

Molar incisor enamel hypoplasia

197

2.13

4.90

2.0

1.5

3.95

5.10

umol/l

1.25

180

Poisoning by drugs, medicaments and biological substances

121

790

1.54

4.88

1.2

1.3

4.97

5.87

umol/l

1.81

106

739

Emotional disorders starting during childhood or adolecense, excluding more controls

284

1.92

4.87

1.4

7.44

6.45

umol/l

1.04

269

TMD related operations

420

1.75

4.87

1.8

1.2

5.23

5.38

umol/l

0.04

390

Diseases of pulp and periapical tissues, including avohilmo

452

1869

1.26

4.85

1.3

5.15

5.33

umol/l

0.43

416

1728

Selective deficiency of immunoglobulin G [IgG] subclasses

11.75

4.82

4.4

2.6

3.67

6.83

umol/l

—

Cholelithiasis, broad definition with cholecystitis

248

1260

1.35

4.75

1.3

3.97

4.41

umol/l

0.54

228

1160

Accidents

377

1477

1.28

4.66

1.4

1.3

5.22

5.27

umol/l

0.07

346

1384

Infections, IBD-co-morbidities

155

2.07

4.66

1.5

1.3

4.50

4.91

umol/l

0.26

140

Suppurative and unspecified otitis media

221

1441

1.36

4.66

1.4

1.3

5.92

6.07

umol/l

0.23

207

1339

Injuries to the ankle and foot

301

2110

1.30

4.65

1.3

5.49

5.41

umol/l

0.15

272

1955

Migraine with aura and triptan purchases

103

658

1.57

4.62

1.4

1.3

5.32

5.96

umol/l

1.07

616

Carpal tunnel syndrome

158

992

1.44

4.61

1.3

3.43

4.19

umol/l

2.14

135

920

Other external causes of accidental injury

376

1477

1.28

4.57

1.3

5.22

5.27

umol/l

0.08

345

1384

Erosion of teeth

3.89

4.55

1.5

1.9

2.87

4.33

umol/l

1.07

Insulin, intermediate and long-acting

142

957

1.46

4.48

1.4

1.3

4.08

4.53

umol/l

0.85

123

884

Dermatitis

198

1446

1.37

4.44

1.3

4.25

4.97

umol/l

2.21

180

1326

Polyarthrosis

161

2.15

4.42

1.2

2.32

3.23

umol/l

0.68

152

Diseases of external ear

107

697

1.54

4.40

1.2

1.3

4.71

4.87

umol/l

0.20

646

Falls/tendency to fall

481

1954

1.23

4.38

1.3

5.24

5.23

umol/l

0.02

429

1820

Other and unspecified dermatitis

167

1189

1.41

4.37

1.3

4.31

5.03

umol/l

1.92

152

1094

Concussion

196

1237

1.37

4.36

1.4

1.3

4.55

5.55

umol/l

3.46

177

1171

Eating disorders

100

644

1.56

4.35

1.2

5.87

6.41

umol/l

0.95

600

Disorders of ocular muscles, binocular movement, accommodation and refraction

216

1592

1.35

4.34

1.3

5.38

5.39

umol/l

0.01

203

1470

Other systemic involvement of connective tissue

519

1.62

4.33

1.4

1.3

3.98

4.59

umol/l

0.91

485

Diseases of oesophagus, stomach and duodenum

363

1742

1.27

4.33

1.3

3.99

5.01

umol/l

5.90

322

1611

Benign neoplasm of colon, rectum, anus and anal canal

104

477

1.56

4.32

1.2

1.4

3.19

3.64

umol/l

0.68

437

Asthma, hospital admission 2, infections

210

1530

1.35

4.31

1.4

1.3

4.29

5.35

umol/l

3.99

195

1411

Asthma-related infections

210

1530

1.35

4.31

1.4

1.3

4.29

5.35

umol/l

3.99

195

1411

Extrapyramidal and movement disorders

466

1.66

4.30

1.2

1.3

4.30

3.92

umol/l

0.42

434

Chronic gastritis

274

1.86

4.29

1.4

1.3

2.62

3.54

umol/l

1.90

257

Rotator cuff syndrome

128

642

1.48

4.25

1.4

1.2

2.84

3.89

umol/l

3.34

115

593

Melanocytic naevi

117

784

1.50

4.24

1.5

1.3

4.98

5.41

umol/l

0.66

111

727

Single spontaneous delivery

133

1024

0.69

4.21

1.3

1.2

6.01

5.84

umol/l

0.18

126

937

Abnormal findings on diagnostic imaging of lung

449

1.65

4.20

1.6

1.3

2.67

3.29

umol/l

0.92

412

Mental and behavioural disorders due to tobacco

115

2.36

4.15

1.1

1.3

4.27

4.70

umol/l

0.21

109

Erysipelas

104

621

1.53

4.15

1.2

1.3

3.39

3.81

umol/l

0.62

576

Other joint disorders

418

1796

1.24

4.09

1.3

1.2

5.25

5.67

umol/l

1.30

381

1678

Benign neoplasm: Colon

531

1.59

4.08

1.2

1.3

3.12

3.10

umol/l

0.02

486

Functional dyspepsia

520

1.60

4.07

1.5

1.2

4.49

4.81

umol/l

0.38

486

Other chronic obstructive pulmonary disease, including avohilmo

417

1.62

4.05

1.3

1.2

2.34

3.22

umol/l

2.21

381

Fibroblastic disorders

244

1.89

4.04

1.7

1.2

2.94

3.82

umol/l

1.23

224

Hypertrophy of breast in women and men

498

1.61

4.04

1.3

4.89

4.73

umol/l

0.15

464

Other disorders of prostate

10.04

4.01

1.0

3.86

1.67

umol/l

—

Smoking dependency

117

2.32

4.01

1.1

1.3

4.27

4.69

umol/l

0.21

110

Allergic urticaria

231

1.92

4.01

1.5

1.3

6.04

5.21

umol/l

0.60

218

Subjective visual disturbances

523

1.59

3.99

1.2

1.3

5.06

4.92

umol/l

0.12

484

Cervical disc disorders

453

1.64

3.99

1.5

1.2

3.11

3.68

umol/l

0.94

417

Systemic connective tissue disorders

103

682

1.51

3.97

1.3

3.87

4.65

umol/l

1.50

634

Vulvovaginal ulceration/inflammation in other diseases

225

1.93

3.97

1.6

1.2

4.70

5.84

umol/l

1.21

213

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

230

1721

1.32

3.96

1.4

1.3

4.89

5.34

umol/l

1.24

209

1593

Problems related to lifestyle

246

1.88

3.96

1.3

1.2

5.17

6.01

umol/l

0.78

230

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

183

1333

1.36

3.96

1.5

1.3

5.20

5.72

umol/l

1.14

165

1240

Other arthrosis

107

506

1.51

3.94

1.6

1.2

2.57

3.69

umol/l

3.73

468

Disorders of gallbladder, biliary tract and pancreas

280

1400

1.29

3.93

1.3

3.97

4.44

umol/l

0.67

255

1289

Diseases of salivary glands

349

1.72

3.92

1.2

1.3

3.53

4.99

umol/l

2.51

318

Diaphragmatic hernia

417

1.66

3.91

1.2

1.3

3.15

3.56

umol/l

0.53

384

Tinnitus

342

1.73

3.90

1.5

1.2

4.26

4.23

umol/l

0.02

317

Benign paroxysmal vertigo

395

1.67

3.89

1.3

1.2

3.69

3.94

umol/l

0.27

365

Oxicams

227

1.71

3.88

1.4

1.2

4.70

4.90

umol/l

0.15

209

Urticaria and erythema

158

1142

1.39

3.85

1.4

1.3

5.25

5.26

umol/l

0.00

142

1052

Acute laryngitis and tracheitis

497

1.59

3.84

1.3

5.37

6.11

umol/l

0.88

462

Symptoms and signs concerning food and fluid intake

207

1.94

3.80

1.4

4.28

4.69

umol/l

0.34

193

Certain disorders involving the immune mechanism

308

1.76

3.79

1.9

1.4

3.21

4.24

umol/l

1.36

287

Fissure and fistula of anal and rectal regions

391

1.67

3.77

1.2

4.73

4.53

umol/l

0.14

366

Cardiovascular diseases (excluding rheumatic etc)

341

1573

1.25

3.75

1.4

1.3

4.58

5.63

umol/l

6.20

316

1453

Urticaria

140

998

1.41

3.72

1.4

1.3

5.42

5.35

umol/l

0.08

126

920

Asthma, hospital admissions , main diagnosis only

316

2260

1.25

3.71

1.4

1.3

4.26

5.27

umol/l

5.83

289

2089

Abnormalities of gait and mobility

141

2.14

3.70

1.3

1.4

3.31

3.99

umol/l

0.46

128

Asthma (diagnoses ohter than nonallergic)

326

2234

1.25

3.69

1.4

1.3

4.06

5.29

umol/l

8.26

293

2067

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

559

1.54

3.66

1.3

5.17

5.93

umol/l

1.02

526

Disorders of eyelid, lacrimal system and orbit

257

1570

1.29

3.65

1.4

1.3

4.03

4.74

umol/l

2.37

231

1442

Mental and behavioural disorders due to psychoactive substance use

181

1272

1.34

3.64

1.1

1.3

4.80

5.24

umol/l

0.80

161

1182

Hypermetropia

226

1.87

3.59

1.2

1.5

6.13

5.13

umol/l

0.72

204

Insulin, combination of fast acting with intermediate-acting or long-acting

159

1072

1.37

3.59

1.4

1.3

4.21

4.57

umol/l

0.55

138

995

Sequelae of external causes of morbidity and mortality

382

1.65

3.57

1.3

4.06

4.59

umol/l

0.48

354

Benign neoplasm: Colon

409

1.56

3.55

1.2

1.3

3.13

3.54

umol/l

0.50

377

Other bursopathies

137

2.12

3.54

1.3

1.2

3.39

4.17

umol/l

0.61

127

Other disorders of skin and subcutaneous tissue

181

1240

1.34

3.54

1.3

4.25

4.58

umol/l

0.59

164

1135

Benign neoplasm: Colon, unspecified

191

1.93

3.51

1.2

1.3

2.78

3.02

umol/l

0.18

178

Exophthalmic conditions

10.13

3.51

1.7

1.2

6.82

7.73

umol/l

—

Other female pelvic inflammatory diseases

369

1.66

3.50

1.4

1.3

3.82

4.76

umol/l

1.25

345

Melanocytic naevi

117

818

1.43

3.49

1.5

1.3

4.98

5.29

umol/l

0.43

111

760

Other eating disorders

340

1.69

3.48

1.2

6.04

6.77

umol/l

0.81

317

Congenital malformations, deformations and chromosomal abnormalities

267

2022

1.27

3.48

1.5

1.3

4.99

5.58

umol/l

1.94

247

1870

Epilepsy

661

1.48

3.46

1.6

1.3

4.95

4.88

umol/l

0.07

614

Diseases of arteries, arterioles and capillaries

114

588

1.45

3.45

1.1

1.2

3.12

3.74

umol/l

1.28

101

542

Open bite

259

1.79

3.44

1.5

1.4

5.00

5.76

umol/l

0.74

242

Immunodeficiencies

100

2.32

3.43

2.5

1.5

3.66

4.47

umol/l

0.46

Pain in limb

286

1646

1.26

3.40

1.5

1.3

4.21

5.44

umol/l

7.39

263

1521

Substance abuse

173

1238

1.34

3.39

1.1

1.3

4.81

5.22

umol/l

0.74

154

1148

Excessive attrition of teeth

171

685

1.36

3.38

1.3

4.82

5.28

umol/l

1.02

161

636

Acute sinusitis

210

1507

1.30

3.38

1.3

1.2

4.82

5.37

umol/l

1.47

201

1400

Allergic conjunctivitis

238

1835

1.28

3.37

1.4

1.3

4.85

5.29

umol/l

1.25

215

1698

Transport accidents

192

1294

1.32

3.37

1.4

1.2

5.00

5.62

umol/l

1.63

178

1212

Type 1 diabetes, wide definition

562

1.51

3.35

1.5

1.4

4.35

5.20

umol/l

1.81

521

Open wound of wrist and hand

150

1092

1.36

3.34

1.3

5.17

5.48

umol/l

0.55

136

1007

Radiculopathy

168

1.97

3.32

1.6

1.2

2.77

4.13

umol/l

2.38

158

Presence of other functional implants

458

1.49

3.30

1.5

1.3

2.93

3.22

umol/l

0.45

419

Hyperplasia of prostate

128

1.87

3.29

1.1

2.73

2.96

umol/l

0.21

118

Acute bronchitis

128

904

1.39

3.23

1.5

1.3

4.58

4.94

umol/l

0.50

116

835

Type 1 diabetes, wide definition, subgroup 1

543

1.51

3.23

1.6

1.4

4.40

5.30

umol/l

1.98

503

Cervicobrachial syndrome

394

1.60

3.20

1.6

1.2

2.89

4.52

umol/l

4.34

367

Other diseases of pleura

396

1.57

3.20

1.4

1.3

2.70

3.56

umol/l

1.62

361

Chronic sinusitis

134

975

1.38

3.20

1.4

1.2

4.19

5.04

umol/l

2.13

124

902

Injury, poisoning and certain other consequences of external causes

268

1062

1.27

3.19

1.4

1.3

5.16

5.56

umol/l

0.88

249

997

Bacterial Sepsis

498

1.50

3.17

1.3

1.2

3.49

4.04

umol/l

0.75

461

Preparation and fitting of bite rail to mouth

326

1.66

3.16

1.7

1.2

5.27

5.29

umol/l

0.00

307

Haemorrhoids and perianal venous thrombosis

342

1.64

3.12

1.1

1.2

4.66

4.06

umol/l

0.48

321

Congenital malformations and deformations of the musculoskeletal system

388

1.60

3.10

1.9

1.4

4.45

5.57

umol/l

1.93

359

ILD medications: prednisolone, methylprednisolone, prednisone

409

1924

1.20

3.09

1.3

3.92

5.32

umol/l

6.38

370

1783

Disorders of vestibular function (Vertigo)

102

708

1.43

3.08

1.4

1.3

3.89

3.93

umol/l

0.04

644

Unspecified haematuria

414

1.53

3.06

1.3

3.22

3.77

umol/l

0.75

380

Oral corticosteroids

368

1839

1.21

3.06

1.4

1.3

3.68

5.20

umol/l

6.52

333

1696

Heart failure, not strict

143

725

1.36

3.05

1.5

1.3

3.26

3.31

umol/l

0.02

119

672

Insulin, fast-acting

109

773

1.41

3.04

1.5

1.4

4.43

4.92

umol/l

0.65

718

Postmenopausal bleeding

176

1.69

3.03

1.6

1.2

2.37

2.45

umol/l

0.10

163

Azathioprine

361

1.61

3.03

1.3

2.87

5.26

umol/l

8.23

338

Pedal cyclist injured in transport accident

552

1.49

3.02

1.5

1.2

5.14

5.50

umol/l

0.38

510

Other disorders of male genital organs

5.85

3.02

2.0

1.1

1.60

3.77

umol/l

—

Haemorrhage in early pregnancy

139

1004

1.35

3.01

1.2

1.3

4.93

5.22

umol/l

0.46

133

924

Localized swelling, mass and lump of skin and subcutaneous tissue

586

1.47

2.99

1.2

4.10

4.65

umol/l

0.84

541

Benign neoplasm: Colon, unspecified

204

1.82

2.97

1.2

1.3

2.78

3.07

umol/l

0.22

186

Insulin, fast-acting or short human

110

785

1.40

2.97

1.5

1.3

4.39

4.90

umol/l

0.68

729

ILD medications: azathioprine

363

1.60

2.97

1.3

2.87

5.27

umol/l

8.33

340

Transient ischemic attack

437

1.50

2.95

1.3

1.2

2.39

3.09

umol/l

1.95

399

Assault by bodily force

162

1.92

2.94

1.1

1.2

5.79

5.84

umol/l

0.02

155

Venous thromboembolism

105

723

1.41

2.93

1.4

1.3

3.77

3.88

umol/l

0.12

659

Acute suppurative otitis media

167

1190

1.31

2.93

1.3

5.96

6.17

umol/l

0.31

154

1109

Intentional self-harm by unspecified means

3.39

2.92

1.4

1.2

7.01

6.36

umol/l

—

Otitis externa

516

1.50

2.92

1.3

5.31

5.04

umol/l

0.35

479

Chronic rhinitis, nasopharyngitis and pharyngitis

106

755

1.41

2.92

1.5

1.3

4.88

5.08

umol/l

0.18

696

Myopia

452

1.53

2.91

1.2

1.3

5.20

5.77

umol/l

0.71

420

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

516

1.49

2.91

1.6

1.2

4.22

4.88

umol/l

0.94

474

Persons with potential health hazards related to communicable diseases

218

1712

1.27

2.90

1.4

1.3

5.13

5.78

umol/l

2.03

208

1577

Supernumerary teeth EXCLUDE clefts and syndromes

5.58

2.90

2.1

1.3

4.39

5.17

umol/l

—

Other bacterial intestinal infections

243

1.73

2.89

1.6

1.4

4.91

4.51

umol/l

0.23

228

Conjunctivitis (acute, non atopic)

118

855

1.38

2.88

1.2

1.3

4.47

5.31

umol/l

1.98

110

792

Thyrotoxicosis with toxic single thyroid nodule

6.77

2.88

3.7

1.1

4.15

6.51

umol/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

378

1.58

2.86

1.4

1.3

7.15

6.48

umol/l

0.65

347

Dental caries 2 and operation codes, only avohilmo

302

1532

1.22

2.83

1.2

1.3

5.62

5.10

umol/l

1.56

276

1417

Benign neoplasm: Brain, supratentorial

4.49

2.80

1.1

2.90

5.51

umol/l

—

Explicit Sepsis

105

721

1.40

2.79

1.4

1.3

3.42

4.56

umol/l

3.22

662

Persons encountering health services for specific procedures and health care

393

2048

1.19

2.74

1.4

1.3

3.96

5.24

umol/l

9.90

347

1898

Arthropathies

422

1814

1.19

2.72

1.3

5.36

5.64

umol/l

0.76

388

1693

Localized skin eruption due to drugs and medicaments

6.07

2.70

1.2

1.0

5.17

6.30

umol/l

—

Other obstetric conditions, not elsewhere classified

262

1381

1.24

2.70

1.3

1.2

5.79

6.19

umol/l

1.04

240

1288

Dental operations

168

659

1.31

2.68

1.4

1.3

4.31

4.69

umol/l

0.65

158

604

Clear cell adenocarcinoma of kidney

4.23

2.68

1.0

1.6

2.51

1.86

umol/l

—

Speech disturbances, not elsewhere classified

2.18

2.67

1.5

1.3

7.42

4.47

umol/l

0.33

Sub-endpoint used in defining T1D endpoints

101

714

1.39

2.66

1.7

1.4

4.46

5.17

umol/l

1.30

663

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

260

1371

1.23

2.66

1.3

1.2

5.83

6.20

umol/l

0.92

238

1279

Disturbance of activity and attention

578

1.44

2.65

1.4

1.3

6.26

6.17

umol/l

0.08

531

Sequelae with surgical and medical care as external cause

265

1.66

2.65

1.1

1.3

3.90

4.23

umol/l

0.21

246

Injuries to the abdomen, lower back, lumbar spine and pelvis

119

874

1.35

2.64

1.3

4.32

5.21

umol/l

2.10

106

814

Pollen allergy

122

897

1.35

2.64

1.3

5.06

5.96

umol/l

2.17

115

837

Intestinal stricture

327

1.59

2.64

1.5

1.3

3.13

3.67

umol/l

0.52

301

Other noninfective gastroenteritis and colitis

602

1.43

2.63

1.3

4.03

5.14

umol/l

2.32

549

Convulsions, not elsewhere classified

646

1.41

2.59

1.4

1.2

4.34

5.67

umol/l

3.25

601

Adverse effects, not elsewhere classified

630

1.42

2.59

1.3

4.33

5.49

umol/l

2.61

587

Benign neoplasm: Brain, supratentorial

4.04

2.57

1.1

2.90

5.41

umol/l

—

Drug-induced osteoporosis

7.22

2.55

2.8

1.1

3.54

4.21

umol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.54

2.55

2.5

1.2

4.22

5.94

umol/l

—

Chronic lymphocytic leukaemia, helper endpoint

7.17

2.55

1.0

1.1

1.96

1.60

umol/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

7.17

2.55

1.0

1.1

1.96

1.60

umol/l

—

Haemolytic anaemias

2.62

2.53

2.0

1.4

3.94

4.96

umol/l

0.61

Other enthesopathies

509

1.46

2.51

1.4

1.2

3.90

4.69

umol/l

1.21

467

Other/unspecified synovitis and tenosynovitis

179

1.79

2.51

1.2

3.82

4.92

umol/l

0.88

164

Hyperkinetic disorders

627

1.41

2.49

1.4

1.3

6.19

6.14

umol/l

0.04

578

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

239

1587

1.23

2.49

1.3

5.55

5.16

umol/l

0.79

221

1470

Other conjunctival vascular disorders and cysts

4.40

2.48

1.0

1.1

3.81

3.49

umol/l

—

Other septicaemia

509

1.45

2.47

1.4

1.3

3.27

4.17

umol/l

1.73

468

Colonic or urogenital fistula

454

1.48

2.46

1.2

4.71

4.42

umol/l

0.24

421

Diseases of male genital organs

241

1.49

2.42

1.2

1.4

3.56

3.89

umol/l

0.36

219

Salpingitis and oophoritis

335

1.56

2.42

1.5

1.3

3.25

4.02

umol/l

1.00

313

Other spirochaetal diseases

400

1.50

2.39

1.2

1.3

4.27

4.24

umol/l

0.03

372

All influenza

498

1.45

2.39

1.5

1.3

4.65

5.02

umol/l

0.38

463

Other and unspecified effects of external causes

120

905

1.33

2.39

1.3

4.67

5.63

umol/l

2.24

108

843

Exposure to unspecified factor

348

2287

1.18

2.37

1.3

4.84

5.16

umol/l

0.91

314

2115

Postpartum haemorrhage

153

1037

1.29

2.37

1.3

5.87

5.66

umol/l

0.33

148

956

Inflammatory disease of uterus

549

1.43

2.37

1.2

1.3

4.72

5.73

umol/l

1.70

509

Phakomatoses, not elsewhere classified

3.69

2.37

2.0

1.3

2.45

6.36

umol/l

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

6.28

2.37

1.0

2.00

1.75

umol/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

6.29

2.37

1.0

3.68

4.45

umol/l

—

Lyme disease

393

1.50

2.36

1.2

1.3

4.32

4.19

umol/l

0.12

365

Other and unspecified trigeminal disorders

4.15

2.36

2.1

1.0

3.19

7.05

umol/l

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

3.65

2.36

1.0

1.2

2.51

1.98

umol/l

—

Autoimmune diseases excluding thyroid diseases

367

1727

1.18

2.36

1.5

1.2

4.18

5.40

umol/l

7.89

331

1605

Disorders of synovium and tendon

163

1154

1.27

2.35

1.3

1.2

4.53

5.18

umol/l

1.38

147

1066

Other viral diseases, not elsewhere classified

566

1.41

2.33

1.6

1.4

4.28

5.22

umol/l

1.77

523

Type of accident

711

1.37

2.33

1.3

4.61

5.36

umol/l

1.19

654

Glaucoma

548

1.39

2.33

1.3

3.10

3.22

umol/l

0.16

504

Diseases of the digestive system

113

846

1.33

2.32

1.4

1.3

3.84

4.65

umol/l

1.76

101

784

Female genital prolapse

242

1.50

2.32

1.4

1.1

3.06

3.39

umol/l

0.40

223

Delivery

153

1035

0.78

2.32

1.2

1.3

6.05

5.87

umol/l

0.24

144

948

Other acute lower respiratory infections

176

1337

1.26

2.31

1.5

1.3

4.81

5.32

umol/l

0.98

161

1236

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

213

1515

1.23

2.29

1.4

1.3

5.02

5.24

umol/l

0.41

202

1401

Postpartum care and examination

127

615

1.32

2.29

1.3

6.71

6.37

umol/l

0.50

120

565

Infections with a predominantly sexual mode of transmission

159

1252

1.27

2.29

1.3

1.2

5.70

5.80

umol/l

0.14

146

1162

Crossbite

315

1.54

2.28

1.8

1.4

4.88

5.29

umol/l

0.37

293

Disorders of oesophagus in diseases classified elsewhere

4.64

2.27

1.8

4.12

4.06

umol/l

—

Other appendicitis

134

1.87

2.26

1.4

1.3

6.93

4.50

umol/l

0.34

128

Gonarthrosis

128

557

1.32

2.26

1.4

1.2

2.58

3.78

umol/l

3.68

115

513

Papulosquamous disorders

673

1.37

2.25

1.2

1.4

4.15

4.26

umol/l

0.10

620

malignant neoplasm of male genital organs

139

1.69

2.24

1.0

1.1

2.28

2.83

umol/l

0.69

127

Septicaemia

575

1.39

2.21

1.4

1.3

3.32

4.18

umol/l

1.63

527

AV-block

122

1.86

2.21

1.0

1.3

3.59

3.69

umol/l

0.04

113

Viral and other specified intestinal infections

126

947

1.30

2.20

1.4

1.3

5.21

6.38

umol/l

2.89

114

877

Intracranial injury

187

1459

1.24

2.18

1.4

1.3

4.83

5.40

umol/l

1.33

170

1353

Asthma and allergy

535

1.41

2.18

1.7

1.2

4.31

5.96

umol/l

3.57

510

Parodontitis and operation codes

206

1303

1.23

2.18

1.2

1.3

3.62

4.40

umol/l

2.64

176

1208

Dermatographic urticaria

173

1.74

2.17

1.1

1.2

4.35

5.18

umol/l

0.64

165

Complications of labour and delivery

309

1453

1.19

2.16

1.3

5.55

5.46

umol/l

0.16

288

1336

Diseases of inner ear

114

849

1.32

2.16

1.4

1.3

3.94

4.04

umol/l

0.11

105

774

Asthma and allergy, excluding more controls

538

1.40

2.12

1.7

1.3

4.31

5.92

umol/l

3.46

513

Haemorrhage from respiratory passages

381

1.46

2.12

1.3

1.2

4.60

4.26

umol/l

0.09

357

Injury of muscle and tendon at shoulder and upper arm level

379

1.48

2.11

1.4

1.2

3.07

3.28

umol/l

0.22

347

Dental caries, including avohilmo

235

989

1.22

2.09

1.3

4.58

4.82

umol/l

0.37

224

901

204

1.66

2.08

2.4

1.4

4.96

umol/l

0.00

186

Dental caries 3 and operation codes

296

1279

1.19

2.08

1.3

4.65

4.93

umol/l

0.58

275

1170

Dental caries 1

235

990

1.21

2.07

1.3

4.58

4.82

umol/l

0.37

224

902

ILD medications

432

2062

1.15

2.05

1.3

4.17

5.40

umol/l

5.36

389

1912

Dental pulpitis 2, only avohilmo

217

909

1.22

2.05

1.3

4.85

4.89

umol/l

0.05

207

828

Rosacea

176

1.71

2.05

1.5

1.3

4.26

4.52

umol/l

0.18

166

Deep bite

398

1.43

2.05

1.5

1.4

4.84

5.64

umol/l

0.84

370

COPD (mode)

193

1.61

2.05

1.3

1.2

1.78

3.28

umol/l

3.29

185

Dental caries 1 and operation codes

266

1141

1.20

2.03

1.3

4.61

4.89

umol/l

0.51

248

1041

Spontaneous rupture of synovium and tendon

2.11

2.02

1.7

1.2

3.96

3.85

umol/l

0.04

Atherosclerosis, excluding cerebral and coronary sclerosis

227

1.55

2.01

1.1

1.3

2.15

2.50

umol/l

0.47

207

Propionic acid derivatives

125

483

1.30

2.00

1.3

6.09

5.72

umol/l

0.47

116

453

Other and unspecified urticaria

602

1.37

2.00

1.4

1.3

5.68

5.35

umol/l

0.36

560

Conduction disorders

297

1.48

2.00

1.3

1.4

4.29

4.14

umol/l

0.09

272

Benign neoplasm: Cerebral meninges

2.01

2.00

1.5

1.4

2.39

3.68

umol/l

1.49

COPD

322

1.46

1.99

1.4

1.2

2.22

3.41

umol/l

2.28

297

Nonsuppurative otitis media

154

1064

1.25

1.99

1.4

1.3

6.22

6.44

umol/l

0.29

138

994

Gonarthrosis [arthrosis of knee](FG)

143

662

1.27

1.98

1.4

1.3

2.50

3.59

umol/l

3.76

129

603

Nonhereditary hypogammaglobulinemia

4.59

1.94

3.0

1.1

4.24

7.07

umol/l

—

Fasciculation

4.59

1.94

1.2

1.1

4.64

7.42

umol/l

—

Carcinoma in situ of other and unspecified sites

4.56

1.94

1.0

1.2

5.48

1.54

umol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

259

1282

1.19

1.93

1.3

5.61

5.75

umol/l

0.23

241

1186

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

113

875

1.29

1.93

1.4

1.3

4.77

5.49

umol/l

1.34

105

808

Lichen ruber planus, wide definition including periferal and oral lichen planus

258

1.55

1.91

1.4

1.3

3.71

3.69

umol/l

0.01

240

Other arrhythmias

184

1152

1.22

1.90

1.3

3.47

4.87

umol/l

6.31

169

1061

Colorectal cancer, excluding all cancers (controls excluding all cancers)

204

1.61

1.90

1.1

1.3

1.73

2.93

umol/l

3.71

190

Intracranial trauma

208

1287

1.21

1.89

1.4

1.3

4.55

5.53

umol/l

3.47

188

1219

Other diseases of anus and rectum

397

1.44

1.88

1.3

1.2

4.01

4.27

umol/l

0.18

372

Parodontitis

216

1324

1.20

1.88

1.2

1.3

3.61

4.43

umol/l

3.09

185

1226

GI-bleeding

373

1.45

1.87

1.3

3.45

4.18

umol/l

1.20

344

Operations 2 for CAVS

177

1.66

1.87

1.0

1.2

2.43

2.77

umol/l

0.30

164

Calcific aortic valvular stenosis, diagnosis (helper)

177

1.66

1.87

1.0

1.2

2.43

2.77

umol/l

0.30

164

Chronic periodontitis, including avohilmo

215

1323

1.20

1.87

1.2

1.3

3.61

4.43

umol/l

3.08

184

1225

Calcific aortic valvular stenosis, including rheumatic fever

177

1.66

1.87

1.0

1.2

2.43

2.77

umol/l

0.30

164

Other viral diseases

137

1089

1.26

1.87

1.4

1.3

4.82

5.67

umol/l

2.25

129

1006

Other skin changes

228

1.58

1.86

1.2

1.3

5.03

4.49

umol/l

0.35

211

Embedded and impacted teeth

186

1301

1.22

1.86

1.3

6.52

6.46

umol/l

0.09

171

1224

Parodontitis or operation codes

216

1325

1.20

1.85

1.2

1.3

3.61

4.43

umol/l

3.09

185

1227

Other retinal disorders

115

719

1.29

1.84

1.3

1.2

3.62

3.92

umol/l

0.47

665

Biological medicines for asthma

3.56

1.84

1.8

1.1

1.27

5.55

umol/l

—

Gonarthrosis, primary, with knee surgery

442

1.37

1.82

1.2

1.3

2.08

2.69

umol/l

0.87

398

Noninfective enteritis and colitis

155

1256

1.23

1.81

1.4

1.3

3.89

5.24

umol/l

5.55

143

1155

Other chronic obstructive pulmonary disease

311

1.44

1.81

1.4

1.2

2.22

3.41

umol/l

2.16

288

Calcific aortic valvular stenosis, operated

179

1.64

1.80

1.0

1.3

2.43

2.76

umol/l

0.29

166

Calcific aortic valvular stenosis

179

1.64

1.80

1.0

1.3

2.43

2.76

umol/l

0.29

166

Disorders of lens

117

575

1.28

1.80

1.4

1.3

2.71

3.46

umol/l

1.65

110

532

Complications of internal orthopaedic prosthetic devices, implants and grafts

191

1.63

1.80

1.1

1.3

2.42

3.17

umol/l

0.47

176

Medical abortion

230

1485

0.84

1.80

1.4

1.2

5.12

5.54

umol/l

0.91

210

1374

Emotional disorders starting during childhood or adolescence

384

1.43

1.77

1.4

7.44

6.41

umol/l

1.12

355

Other diseases of the digestive system

378

1.43

1.77

1.3

3.57

4.21

umol/l

0.76

349

Injuries to the wrist and hand

355

2242

1.15

1.76

1.3

5.11

5.18

umol/l

0.15

330

2068

Dental caries 1, only avohilmo

240

1033

1.19

1.75

1.3

4.57

4.76

umol/l

0.29

230

939

Malignant neoplasm of breast

667

0.73

1.75

1.4

2.63

3.39

umol/l

1.59

605

Assault

322

1.46

1.73

1.1

1.2

5.42

5.77

umol/l

0.20

302

Perineal laceration during delivery

130

927

1.25

1.73

1.1

1.2

6.30

6.15

umol/l

0.17

119

861

Colorectal cancer

170

1.65

1.73

1.0

1.3

1.91

3.05

umol/l

2.49

153

Neuralgia and neuritis, unspecified

2.14

1.71

2.2

1.1

3.38

5.10

umol/l

1.10

Maternal care for other known or suspected fetal problems

186

988

1.21

1.71

1.2

6.15

6.14

umol/l

0.01

175

917

Residual foreign body in soft tissue

2.07

1.70

1.5

1.1

3.54

5.34

umol/l

0.97

Synovial cyst of popliteal space [Baker]

2.06

1.70

1.2

3.48

4.20

umol/l

0.28

Bacterial intestinal infections, IBD co-morbidities

258

1.51

1.70

1.6

1.4

4.78

4.42

umol/l

0.20

239

Contact with and exposure to communicable diseases

187

1553

1.20

1.69

1.4

1.3

5.51

5.91

umol/l

0.89

180

1435

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

140

714

1.24

1.69

1.4

1.2

3.95

4.97

umol/l

3.18

127

653

Supplementary factors related to causes of morbidity and mortality classified elsewhere

102

796

1.28

1.68

1.3

4.52

5.38

umol/l

1.54

735

Dental pulpitis 2

209

894

1.20

1.68

1.3

4.99

4.89

umol/l

0.11

198

814

Chronic kidney disease

250

1.51

1.66

1.2

1.4

2.82

3.51

umol/l

0.89

229

Covid-19 confirmed case

719

1.30

1.65

1.2

1.3

5.23

5.41

umol/l

0.16

668

Exposure to other specified factors

258

2077

1.17

1.65

1.3

5.02

5.28

umol/l

0.54

236

1920

Other disorders of urethra and urinary system

240

1532

1.17

1.64

1.5

1.2

4.15

5.22

umol/l

5.37

219

1414

Melanocytic naevi of other and unspecified parts of face

112

1.79

1.64

1.5

1.3

5.50

5.28

umol/l

0.10

107

Pregnancy hypertension

193

1459

1.19

1.63

1.4

1.3

5.11

5.33

umol/l

0.38

183

1347

Peripheral artery disease

268

1.44

1.62

1.1

1.3

2.29

3.01

umol/l

1.17

245

Retention of urine

289

1.43

1.62

1.2

3.25

3.96

umol/l

0.72

270

Other and unspecified hydrocephalus

3.59

1.62

1.0

1.9

4.68

3.86

umol/l

—

Epiphora

3.59

1.61

1.0

1.1

2.40

4.11

umol/l

—

False labour

209

1106

1.19

1.61

1.3

1.2

5.84

5.97

umol/l

0.18

200

1024

Fall on same level

438

2173

1.13

1.60

1.3

4.91

5.21

umol/l

0.90

401

2013

Malignant neoplasm of breast, HER2-negative

643

0.74

1.60

1.3

1.4

2.53

3.36

umol/l

1.78

582

Other and unspecified mental retardation

2.02

1.60

1.3

1.9

4.41

3.63

umol/l

0.47

178

1.60

1.56

1.7

1.4

5.35

4.95

umol/l

0.23

160

Autoimmune diseases excluding thyroid diseases, strict definition

337

1644

1.14

1.55

1.4

1.2

4.29

5.46

umol/l

6.62

302

1529

Sarcoidosis

160

1.63

1.55

1.8

1.3

2.74

4.05

umol/l

1.21

149

Fall on and from stairs and steps

500

1.34

1.54

1.5

1.3

4.54

4.99

umol/l

0.49

464

Mental and behavioural disorders due to alcohol, excluding acute intoxication

101

797

1.27

1.54

1.1

1.2

4.40

4.99

umol/l

0.97

743

Benign neoplasm: Conjunctiva

2.43

1.54

2.4

1.3

4.78

5.39

umol/l

—

Impetigo

130

1.70

1.53

1.2

1.3

3.26

5.21

umol/l

2.30

120

Ganglion

501

1.34

1.53

1.2

5.18

5.22

umol/l

0.02

464

Premature rupture of membranes

149

901

1.22

1.53

1.2

6.31

5.96

umol/l

0.59

135

838

Maternal care for cervical incompetence

115

1.75

1.53

1.3

6.76

5.40

umol/l

0.54

110

Benign neoplasm: Cerebral meninges

100

1.80

1.53

1.5

2.39

3.62

umol/l

1.43

Certain zoonotic bacterial diseases

3.35

1.52

2.0

1.0

4.98

4.91

umol/l

—

Myeloid leukaemia

3.35

1.52

1.0

1.1

2.40

4.71

umol/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

567

0.75

1.52

1.4

2.69

3.67

umol/l

2.15

520

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

567

0.75

1.52

1.4

2.69

3.67

umol/l

2.15

520

Angina pectoris

412

1.31

1.51

1.3

1.2

1.74

2.76

umol/l

4.21

379

Lack of expected normal physiological development

147

1.62

1.51

1.3

1.5

5.18

5.04

umol/l

0.06

137

Gonarthrosis,primary

147

759

1.22

1.49

1.3

2.37

3.20

umol/l

2.68

135

685

Dental caries 3

259

1140

1.16

1.49

1.3

4.65

4.88

umol/l

0.38

241

1042

Asthma-related pneumonia

643

1.29

1.47

1.5

1.3

3.45

4.68

umol/l

2.57

592

COPD related to multimorbidity

245

1.44

1.46

1.3

1.83

2.85

umol/l

2.14

223

Superficial injury of ankle and foot

411

1.37

1.46

1.5

1.2

5.69

5.76

umol/l

0.05

386

Oral leukoplakia and related diseases, including avohilmo

1.84

1.45

1.1

1.4

2.89

3.63

umol/l

0.42

Paroxysmal tachycardia

419

1.33

1.45

1.2

1.3

3.15

5.00

umol/l

4.27

387

Other medical care

656

1.28

1.44

1.3

3.93

4.59

umol/l

1.00

606

Injuries to the neck

664

1.28

1.44

1.7

1.2

4.37

5.74

umol/l

3.02

622

Myeloid leukaemia

3.14

1.44

1.0

2.40

4.77

umol/l

—

Syphilis

3.14

1.44

1.4

1.1

3.28

4.34

umol/l

—

Psoriasis vulgaris

277

1.45

1.44

1.1

1.3

4.33

4.63

umol/l

0.21

260

Acquired haemolytic anaemia

2.74

1.43

1.0

1.5

2.95

4.56

umol/l

—

Psoriasis

481

1.33

1.43

1.1

1.3

4.09

4.50

umol/l

0.44

448

Postpartum hemorraghe, all women as controls

153

1271

1.20

1.43

1.3

1.2

5.87

5.71

umol/l

0.25

148

1171

Ectopic pregnancy

534

1.31

1.42

1.2

1.3

5.25

4.88

umol/l

0.36

496

Asthma-related pneumonia or sepsis

648

1.28

1.40

1.5

1.3

3.45

4.68

umol/l

2.57

596

Asthma, hospital admissions 3, pneumonia

648

1.28

1.40

1.5

1.3

3.45

4.68

umol/l

2.57

596

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

301

1.37

1.40

1.1

1.3

2.14

3.02

umol/l

1.58

274

Atrial fibrillation and flutter with reimbursement

145

1.50

1.39

1.1

1.2

2.12

3.18

umol/l

1.04

133

Allergic asthma (mode)

105

830

1.24

1.39

1.5

1.2

4.62

5.80

umol/l

2.87

784

Cerebral aneurysm, nonruptured

1.77

1.38

1.3

1.4

2.62

3.65

umol/l

1.10

Personal history of other diseases and conditions

534

1.31

1.38

1.4

1.3

5.46

5.55

umol/l

0.07

496

Chromosomal abnormalities, not elsewhere classified

1.78

1.38

2.5

1.6

3.81

4.60

umol/l

0.45

Melanocytic naevi of other and unspecified parts of face

119

1.69

1.37

1.5

1.3

5.50

5.12

umol/l

0.19

113

Renal tubulo-interstitial diseases

216

1919

0.86

1.37

1.3

4.01

5.09

umol/l

4.78

199

1770

Volume depletion

1.80

1.37

1.5

1.7

5.41

4.25

umol/l

0.50

Abnormal findings in secretions and smears from cervix uteri vagina vulva

222

1506

1.16

1.36

1.3

5.69

5.24

umol/l

0.96

206

1395

Other obstetric trauma

235

0.55

1.35

1.2

5.80

5.69

umol/l

0.04

219

Acute pancreatitis

207

1.50

1.34

1.7

1.2

3.08

4.29

umol/l

1.35

192

Diabetic retinopathy

501

0.75

1.34

1.4

1.3

3.70

4.55

umol/l

1.30

457

Artrosis, including avohilmo

202

947

1.17

1.33

1.4

1.3

3.50

4.39

umol/l

3.49

181

870

Benign neoplasm: Transverse colon

1.97

1.32

1.1

1.4

2.48

3.29

umol/l

0.62

Pacemaker

234

1.45

1.31

1.0

1.3

2.49

3.14

umol/l

0.59

214

Other bacterial diseases

248

1495

1.15

1.31

1.2

1.3

3.58

4.65

umol/l

4.92

216

1377

Allergic asthma (mode), excluding more controls

105

837

1.23

1.30

1.5

1.2

4.62

5.75

umol/l

2.67

791

Parodontitis, under 40 years

490

1.31

1.29

1.3

1.2

5.92

6.51

umol/l

0.77

462

Parodontitis, under 40 years, or operation codes

490

1.31

1.29

1.3

1.2

5.92

6.51

umol/l

0.77

462

COPD, hospital admissions

340

1.34

1.29

1.4

1.2

2.22

3.26

umol/l

1.78

313

Delivery, wide proxy

146

925

0.84

1.27

1.2

6.32

6.06

umol/l

0.36

137

847

Benign neoplasm: Conjunctiva

2.29

1.27

2.4

1.5

4.77

5.20

umol/l

—

Chronic lower respiratory diseases

445

2175

1.11

1.26

1.4

1.3

4.30

5.33

umol/l

4.00

402

2016

Appendectomy

217

1816

1.15

1.26

1.2

1.3

4.90

5.17

umol/l

0.47

200

1674

COPD, early/later onset

341

1.34

1.25

1.4

1.2

2.22

3.25

umol/l

1.76

314

Arthrosis

154

712

1.19

1.25

1.6

1.2

3.13

4.33

umol/l

4.34

135

661

Single delivery by forceps and vacuum extractor

727

0.81

1.23

1.2

5.69

6.19

umol/l

0.78

674

Inflammatory bowel disease treatment related agents

409

2095

1.11

1.23

1.3

3.95

5.37

umol/l

6.52

369

1941

Renal failure

395

1.32

1.22

1.4

1.3

2.61

3.48

umol/l

1.85

365

Dental operations, only avohilmo

166

721

1.18

1.22

1.4

1.3

4.23

4.71

umol/l

0.83

158

655

Nutritional anaemias

111

890

1.21

1.3

3.25

4.55

umol/l

4.38

104

817

Other and unspecified rosacea

116

1.64

1.21

1.3

4.75

4.42

umol/l

0.16

110

Drug-induced neutropenia

1.80

1.21

1.1

1.4

1.81

4.19

umol/l

4.17

Malignant neoplasm of digestive organs

292

1.38

1.20

1.1

1.2

1.96

2.80

umol/l

2.01

269

Sulfonylureas

169

1.46

1.19

1.2

1.3

2.69

2.40

umol/l

0.18

153

Other fall from one level to another

656

1.25

1.19

1.4

1.3

4.90

5.66

umol/l

1.12

608

Paracetamol of NSAID medication

349

1.26

1.19

1.5

1.3

5.68

5.92

umol/l

0.23

331

Senile cataract

443

1.25

1.18

1.2

1.3

2.17

3.15

umol/l

2.39

406

Non-rheumatic valve diseases

445

1.26

1.17

1.3

2.65

3.83

umol/l

3.43

409

Heart failure and antihypertensive medication

140

1.46

1.16

1.6

1.3

2.92

3.83

umol/l

0.76

132

Other cataract

371

1.29

1.15

1.3

2.48

3.14

umol/l

1.03

343

Dental caries 3, only avohilmo

260

1173

1.13

1.14

1.3

4.64

4.86

umol/l

0.35

242

1069

Fracture of lower leg, including ankle

142

1202

1.18

1.13

1.2

1.3

4.50

4.78

umol/l

0.32

125

1107

Alcohol use disorder, Swedish definition

127

992

1.19

1.13

1.1

1.3

4.39

4.94

umol/l

1.04

116

919

Other disorders of amniotic fluid and membranes

718

1.23

1.13

1.1

1.3

6.23

5.78

umol/l

0.59

665

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

293

1874

1.12

1.13

1.4

1.3

3.99

4.87

umol/l

3.56

272

1717

Bacterial infection, other or unspecified

694

1.22

1.11

1.2

1.3

3.22

4.17

umol/l

2.02

642

Diabetic retinopathy, excluding more controls

415

0.77

1.11

1.4

1.3

3.79

4.95

umol/l

1.98

380

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

236

1228

1.14

1.10

1.4

1.3

3.50

4.49

umol/l

4.28

213

1126

Parodontitis, under 40 years and operation codes

477

1.28

1.09

1.3

1.2

5.96

6.51

umol/l

0.66

451

Gout

160

1.48

1.09

1.0

1.1

2.93

3.15

umol/l

0.16

144

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

201

1.44

1.09

1.2

1.3

2.91

3.16

umol/l

0.17

188

Recurrent dislocation and subluxation of joint

144

1.53

1.08

1.3

1.2

5.11

4.98

umol/l

0.06

138

Parodontitis, operation under 40 years and operation codes

478

1.28

1.08

1.3

1.2

5.96

6.52

umol/l

0.67

452

Insulin, fast-acting (human)

329

1.34

1.08

1.5

1.3

4.17

5.30

umol/l

1.81

311

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

167

1443

1.16

1.08

1.2

1.3

5.93

5.80

umol/l

0.17

151

1342

Statin medication

186

905

1.15

1.07

1.4

1.3

3.50

4.55

umol/l

3.63

167

834

Other benign neoplasms of skin

574

1.25

1.07

1.3

3.94

4.30

umol/l

0.41

533

Other and unspecified iron deficiency

649

1.23

1.05

1.3

3.58

4.82

umol/l

2.84

600

Congenital malformations of heart and great arteries

389

1.30

1.03

1.3

1.4

4.58

4.93

umol/l

0.26

364

L04AA Selective immunosuppressants

440

0.73

1.02

1.5

1.4

3.57

4.59

umol/l

1.04

407

Valvular heart disease excluding rheumatic fever

461

1.24

1.02

1.3

1.4

2.62

3.82

umol/l

3.59

422

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

311

1905

1.11

1.02

1.5

1.3

3.90

5.06

umol/l

7.61

282

1759

Anti-inflammatory and antirheumatic products, non-steroids

115

484

1.20

1.02

1.3

6.09

5.71

umol/l

0.47

106

454

Congenital malformations of the circulatory system

433

1.28

1.01

1.3

1.4

4.38

5.01

umol/l

0.60

405

Dislocation, sprain and strain of joints and ligaments of knee

202

1655

1.13

1.00

1.3

4.87

5.32

umol/l

1.00

188

1534

Cardiac arrhythmias

200

1162

1.14

1.00

1.3

3.65

5.30

umol/l

9.06

180

1078

Disorders of breast

175

1418

1.14

0.99

1.4

1.3

4.55

5.02

umol/l

0.90

158

1307

Malignant neoplasm, wide definition for exclusion

234

1228

1.13

0.99

1.4

1.3

3.52

4.49

umol/l

4.13

211

1126

Impacted teeth

137

1096

1.17

0.99

1.3

6.49

6.69

umol/l

0.29

127

1030

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

234

1228

1.13

0.99

1.4

1.3

3.52

4.49

umol/l

4.13

211

1126

Codes for special purposes

166

1448

1.15

0.98

1.2

1.3

5.31

5.53

umol/l

0.32

145

1342

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

1.81

0.98

1.1

1.3

4.95

4.70

umol/l

0.06

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

2.18

0.98

1.0

1.2

3.26

2.94

umol/l

—

Contact with sharp glass

1.67

0.98

1.1

6.84

5.82

umol/l

0.58

Seropositive rheumatoid arthritis, strict definition

224

0.62

0.97

1.5

1.3

2.34

4.13

umol/l

1.79

207

Tic and related disorders

1.81

0.97

2.3

1.3

4.54

5.39

umol/l

—

Puerperal sepsis

275

1.35

0.97

1.8

1.2

3.16

4.38

umol/l

1.87

258

Chronic ulcer of skin, not elsewhere classified

1.85

0.96

1.3

3.49

3.69

umol/l

—

Slow fetal growth and fetal malnutrition

1.88

0.96

1.4

4.23

3.49

umol/l

—

Iron deficiency anaemia

805

1.19

0.95

1.3

3.33

4.66

umol/l

4.01

743

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

296

1676

1.11

0.94

1.4

1.2

4.49

5.11

umol/l

2.11

268

1553

296

1676

1.11

0.94

1.4

1.2

4.49

5.11

umol/l

2.11

268

1553

Metatarsalgia

150

1.47

0.92

1.2

4.09

4.86

umol/l

0.57

139

Provisional assignment of new diseases of uncertain etiology

165

1447

1.14

0.92

1.2

1.3

5.32

5.52

umol/l

0.29

144

1341

Haemangioma, any site

142

1.48

0.92

1.0

1.4

4.03

4.53

umol/l

0.23

132

Acute pancreatitis (for exclusion)

226

1.37

0.92

1.7

1.3

3.08

3.95

umol/l

0.85

209

Use of rivastigmine

1.82

0.91

1.1

1.4

3.32

2.20

umol/l

—

Cardiac murmurs and other cardiac sounds

353

1.29

0.91

1.7

1.4

4.57

5.71

umol/l

1.09

329

Other predominantly sexually transmitted diseases, not elsewhere classified

655

1.21

0.89

1.3

6.39

5.80

umol/l

0.79

615

Atopic dermatitis, strict definition with reimbursement

160

1363

1.14

0.88

1.4

1.3

4.98

5.98

umol/l

2.77

152

1266

Preterm labour and delivery

784

1.19

0.88

1.4

1.3

4.90

4.82

umol/l

0.07

715

Other congenital malformations of skin

1.58

0.87

1.3

1.4

4.86

5.15

umol/l

0.11

Haemangioma, any site

144

1.46

0.87

1.0

1.4

4.03

4.54

umol/l

0.24

134

Stroke, including SAH

523

0.81

0.86

1.2

2.45

3.19

umol/l

1.74

475

Placenta praevia

192

0.62

0.86

1.6

1.2

5.49

5.36

umol/l

0.07

181

Endometriosis ASRM stages 1,2

631

1.21

0.85

1.2

1.3

4.34

5.35

umol/l

1.51

587

Overjet

128

1.49

0.84

2.2

1.4

4.37

5.38

umol/l

0.58

119

Focal epilepsy, strict definition

379

1.27

0.84

1.5

1.4

5.13

4.64

umol/l

0.41

350

Mental and behavioural disorders due to alcohol

122

1028

1.16

0.84

1.1

1.3

4.69

5.15

umol/l

0.76

111

958

Other benign neoplasms of skin

605

1.21

0.84

1.3

1.2

3.94

4.20

umol/l

0.27

560

Childhood asthma (age<16)

661

1.18

0.83

1.2

5.74

6.48

umol/l

1.26

625

Polyarthropathies

158

1194

0.88

0.83

1.2

3.79

5.21

umol/l

5.55

138

1105

Disorders of sclera, cornea, iris and ciliary body

141

1235

1.14

0.83

1.3

4.67

4.88

umol/l

0.26

126

1142

Childhood asthma (age<16), excluding more controls

661

1.18

0.83

1.2

5.74

6.47

umol/l

1.24

625

Sequelae of injuries, of poisoning and of other consequences of external causes

407

1.25

0.83

1.6

1.3

4.28

4.83

umol/l

0.64

378

Burns and corrosions of external body surface, specified by site

240

1.34

0.82

1.3

1.4

4.14

5.33

umol/l

1.12

224

Haemorrhagic and haematological disorders of fetus and newborn

148

1.43

0.81

1.6

1.7

3.86

4.18

umol/l

0.21

133

Brain meningioma, excluding all cancers (controls excluding all cancers)

1.71

0.80

1.3

1.2

1.39

3.42

umol/l

—

Pneumonia, organism unspecified

267

1756

1.10

0.80

1.4

1.3

4.28

4.94

umol/l

2.17

240

1616

Pre-eclampsia

737

1.18

0.80

1.4

1.3

5.04

5.20

umol/l

0.17

675

Other abnormal products of conception

181

1074

1.12

0.80

1.2

1.3

5.66

5.62

umol/l

0.04

176

997

Other enthesopathy of foot (+metatarsalgia)

164

1.40

0.79

1.2

4.40

4.87

umol/l

0.29

153

Dislocation, sprain and strain of joints and ligaments at neck level

491

1.22

0.79

1.8

1.2

3.94

6.03

umol/l

5.25

462

Fall on same level involving ice and snow

151

1335

1.13

0.79

1.5

1.3

4.38

5.05

umol/l

1.40

129

1237

Conduct disorder

1.63

0.78

1.8

1.4

4.84

6.06

umol/l

0.46

STROKE

581

1.17

0.78

1.3

2.66

3.75

umol/l

3.59

541

Diagnoses used for exclusion with ILD

286

1.29

0.78

1.9

1.3

3.30

3.81

umol/l

0.48

265

Ischaemic heart disease, wide definition

111

599

1.16

0.78

1.3

1.93

3.26

umol/l

6.56

552

Primary_lymphoid and hematopoietic malignant neoplasms

260

1.31

0.77

1.0

1.3

2.63

3.82

umol/l

1.82

242

Other and unspecified tonsillitis

170

1286

1.12

0.76

1.3

5.44

6.01

umol/l

1.24

158

1196

Retinal detachments and breaks

358

1.26

0.76

1.4

1.2

3.03

3.31

umol/l

0.26

334

Bacterial pneumonia (organism specified)

708

1.17

0.76

1.4

1.3

4.55

4.76

umol/l

0.21

655

Volvulus

2.09

0.74

2.2

1.4

3.26

4.25

umol/l

—

Injuries to the thorax

734

1.17

0.74

1.5

1.2

4.58

4.70

umol/l

0.10

675

Postpartum haemorrhage due to retained placenta

514

1.21

0.74

1.1

1.3

6.03

5.59

umol/l

0.53

482

Viral infections characterized by skin and mucous membrane lesions

122

1069

1.14

0.74

1.4

1.3

4.61

5.01

umol/l

0.69

114

985

Fracture of foot, except ankle

662

1.18

0.72

1.7

1.2

4.48

5.44

umol/l

1.45

616

Primary open-angle glaucoma

205

1.33

0.72

1.8

1.3

2.14

2.45

umol/l

0.30

188

Cerebrovascular diseases

696

0.85

0.72

1.2

1.3

2.80

3.32

umol/l

1.11

638

Myocardial infarction, strict

310

0.78

0.72

1.1

1.2

1.58

2.97

umol/l

6.02

283

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

1.55

0.71

1.6

1.4

4.38

4.41

umol/l

0.01

Postmenopausal atrophic vaginitis

189

1.27

0.71

1.3

1.2

4.66

2.68

umol/l

0.41

175

Bacterial pneumonia, not elsewhere classified

594

1.18

0.71

1.4

1.2

4.62

4.78

umol/l

0.14

551

Conductive and sensorineural hearing loss

152

936

1.12

0.71

1.3

3.10

4.00

umol/l

2.76

134

862

Alcohol dependence

335

1.25

0.71

1.2

1.3

2.39

4.19

umol/l

5.38

313

Diseases of appendix

224

1858

1.10

0.71

1.2

1.3

5.11

5.00

umol/l

0.10

209

1711

Bacterial pneumoniae

645

1.17

0.70

1.4

1.2

4.60

4.82

umol/l

0.22

597

Sensorineural hearing loss

131

810

1.13

0.69

1.3

2.83

3.83

umol/l

3.28

117

748

Other assisted single delivery

0.55

0.67

1.2

4.74

5.27

umol/l

—

Glaucoma-related operations

1.63

0.67

1.9

1.3

3.01

3.21

umol/l

—

Injuries to the knee and lower leg

410

2193

1.07

0.66

1.2

1.3

4.76

5.24

umol/l

1.78

375

2026

Alcohol use disorder, ICD-based

744

1.16

0.65

1.2

4.44

5.01

umol/l

0.78

695

Pre-eclampsia or eclampsia

763

1.15

0.65

1.4

1.3

5.01

5.17

umol/l

0.16

700

Varicella [chickenpox]

103

1.46

0.65

1.7

1.5

4.44

5.20

umol/l

0.35

Haemangioma and lymphangioma, any site

154

1.37

0.65

1.0

1.4

4.03

4.56

umol/l

0.25

144

Appendicitis, broad definition

221

1849

1.09

0.64

1.2

1.3

5.14

5.01

umol/l

0.11

206

1702

Pregnancy, childbirth and the puerperium

135

793

0.89

0.64

1.2

6.45

6.21

umol/l

0.31

127

726

Influenza and pneumonia

353

2163

1.07

0.64

1.4

1.3

4.47

5.14

umol/l

2.74

320

1996

Atopic dermatitis, strict definition

160

1416

1.11

0.63

1.3

4.96

5.92

umol/l

2.59

151

1311

Internal derangement of knee

810

1.15

0.63

1.2

4.55

5.14

umol/l

0.79

755

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

104

1.45

0.62

1.0

1.4

3.58

4.46

umol/l

0.73

Ischemic heart diseases

115

636

1.13

0.62

1.3

2.09

3.33

umol/l

5.76

585

Benign neoplasm: Other and unspecified parts of mouth

1.67

0.61

1.0

1.1

3.18

4.75

umol/l

—

Injuries to the shoulder and upper arm

209

1604

1.09

0.61

1.4

1.3

4.19

4.92

umol/l

2.27

189

1477

Fracture of skull and facial bones

388

1.21

0.61

1.6

1.3

4.42

5.13

umol/l

0.60

361

Keratitis

786

1.15

0.61

1.3

5.12

4.96

umol/l

0.15

735

Hypertrophy of breast

489

1.19

0.61

1.3

4.75

4.76

umol/l

0.01

455

Injury of muscle and tendon at wrist and hand level

187

0.69

0.60

1.2

1.3

3.81

4.60

umol/l

0.29

175

Primary_lymphoid and hematopoietic malignant neoplasms

271

1.26

0.60

1.0

1.3

2.63

3.80

umol/l

1.78

247

1.51

0.60

2.0

1.1

4.53

6.42

umol/l

1.09

Type 1 diabetes, strict definition, subgroup 1

298

1.24

0.60

1.2

1.4

4.49

5.36

umol/l

1.11

273

Maternal care for known or suspected disproportion

151

0.66

0.59

1.1

1.3

4.28

5.01

umol/l

—

141

Crowding of teeth, including avohilmo

511

1.17

0.59

1.6

1.3

6.06

6.36

umol/l

0.25

474

Other disorders of penis

1.53

0.59

1.1

1.6

3.18

3.40

umol/l

0.07

Acute tubulo-interstitial nephritis

158

1543

0.91

0.58

1.3

4.41

5.22

umol/l

2.24

148

1419

Stroke, excluding SAH

475

0.84

0.58

1.2

2.43

3.17

umol/l

1.63

433

Haemangioma and lymphangioma, any site

158

1.33

0.57

1.0

1.4

4.03

4.65

umol/l

0.31

147

Inguinal or femoral hernia, bilateral

1.54

0.55

1.2

3.32

3.68

umol/l

—

Gout, FINNGEN

203

1.28

0.55

1.0

1.3

2.93

2.90

umol/l

0.02

183

Atrophic disorders of skin

239

1.26

0.55

1.1

1.3

3.50

4.43

umol/l

1.03

223

Other disorders of kidney and ureter

133

1.35

0.55

1.6

1.4

2.42

3.94

umol/l

2.17

121

Malignant neoplasm

212

1159

1.09

0.53

1.4

1.3

3.45

4.26

umol/l

2.86

189

1064

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

1.48

0.53

1.0

1.4

3.00

3.54

umol/l

—

Dental pulpitis 3, only avohilmo

128

843

1.11

0.53

1.3

6.96

6.81

umol/l

0.18

120

790

Unspecified privation

160

1.31

0.53

1.6

1.3

4.69

4.97

umol/l

0.14

148

Maternal care for other conditions predominantly related to pregnancy

109

963

1.12

0.53

1.3

5.15

5.61

umol/l

0.73

888

Calcific tendinitis of shoulder

1.45

0.53

1.1

1.69

4.12

umol/l

—

Diabetic retinopathy, strict definition

422

0.83

0.52

1.6

1.3

4.25

5.00

umol/l

0.74

386

Generalized epilepsy, strict definition

1.52

0.52

1.2

5.49

5.53

umol/l

—

Anisometropia and aniseikonia

1.43

0.52

1.1

1.4

5.22

4.65

umol/l

—

Inguinal hernia, bilateral

1.43

0.52

1.2

3.00

3.63

umol/l

—

Sequelae of infectious and parasitic diseases

0.62

0.52

1.7

1.2

4.23

4.31

umol/l

—

Other disorders of eyelid

490

1.16

0.52

1.1

1.2

2.72

3.30

umol/l

0.85

451

Parkinson's disease, strict definition

1.45

0.51

1.7

1.3

3.63

2.27

umol/l

1.52

Focal epilepsy

443

1.17

0.51

1.5

1.4

5.14

4.73

umol/l

0.34

406

Glucosamine medication

375

1.17

0.51

1.3

1.85

2.38

umol/l

1.37

342

Struck by thrown, projected or falling objec

1.47

0.50

1.9

1.1

4.33

5.83

umol/l

0.59

Superficial injury of head

490

1.16

0.50

1.2

1.3

3.94

5.10

umol/l

2.08

450

Type 1 diabetes, definitions combined

351

1.20

0.50

1.4

4.48

5.26

umol/l

1.02

322

Juvenile arthritis (FINNGEN)

224

0.76

0.49

1.8

1.4

5.94

5.74

umol/l

0.06

207

Burns and corrosions

325

1.20

0.49

1.3

1.4

4.30

5.28

umol/l

1.04

305

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

1.43

0.49

1.2

1.5

2.77

3.89

umol/l

0.73

Dental pulpitis 3

135

885

1.10

0.48

1.3

6.87

6.77

umol/l

0.11

126

828

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

375

1.17

0.48

1.4

1.3

2.71

3.34

umol/l

0.96

345

Type 1 diabetes, strict (exclude DM2)

353

1.19

0.48

1.4

4.48

5.24

umol/l

0.98

324

Spontaneous abortion

202

1274

1.08

0.47

1.2

1.3

5.29

5.36

umol/l

0.10

186

1178

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

300

1982

1.06

0.47

1.4

1.3

4.34

4.98

umol/l

2.29

271

1827

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

1.41

0.46

1.1

1.5

3.68

2.36

umol/l

0.66

Sequelae of other and unspecified infectious and parasitic diseases

0.59

0.45

1.8

1.3

4.32

4.65

umol/l

—

ILD medications: immunosuppressive drugs

177

1572

1.08

0.45

1.3

3.83

5.04

umol/l

4.95

158

1454

Other specified/unspecified arthritis

590

1.14

0.45

1.3

3.45

4.96

umol/l

3.28

554

Graves disease, strict definition

247

1.22

0.44

1.9

1.3

4.77

5.00

umol/l

0.13

231

Disorders of choroid and retina

145

970

1.09

0.44

1.4

1.3

3.44

4.09

umol/l

1.60

125

899

Neonatal jaundice from other and unspecified causes

126

1.32

0.44

1.8

3.24

3.76

umol/l

0.39

111

Congenital malformations of great arteries

102

1.35

0.43

1.1

1.8

4.96

3.61

umol/l

0.87

Rheumatoid arthritis, including avohilmo

672

0.88

0.43

1.2

1.3

3.43

4.13

umol/l

0.94

622

Budesonide

294

1.19

0.42

1.3

2.81

5.23

umol/l

6.66

276

Inguinal hernia

652

0.90

0.42

1.1

1.3

3.52

4.67

umol/l

2.59

600

135

1140

1.09

0.42

1.1

1.3

4.68

5.15

umol/l

0.85

124

1050

Pneumonias (Asthma/COPD co-morbidities)

311

2040

1.06

0.41

1.4

1.3

4.37

5.02

umol/l

2.41

280

1880

Type 1 diabetes, strict definition

313

1.18

0.41

1.2

1.4

4.49

5.26

umol/l

0.95

287

Evidence of alcohol involvement determined by level of intoxication

0.00

0.40

0.0

1.2

—

7.31

—

Fracture of forearm

134

1359

0.92

0.40

1.3

4.83

5.07

umol/l

0.31

120

1254

Nasal polyp

238

0.80

0.40

1.3

1.2

3.59

4.12

umol/l

0.28

225

Acute appendicitis

204

1804

1.07

0.40

1.2

1.3

4.88

5.03

umol/l

0.24

189

1666

Unspecified abortion

101

0.69

0.39

1.3

1.5

2.28

4.05

umol/l

—

Maternal care for known or suspected malpresentation of fetus

113

771

1.09

0.39

1.2

1.3

5.26

5.81

umol/l

1.11

106

715

Presbycusis

1.31

0.39

1.1

1.4

1.54

2.58

umol/l

—

Suggestive for eosinophilic asthma

105

0.67

0.39

1.9

1.3

2.37

4.63

umol/l

—

Paralytic strabismus

1.41

0.39

1.1

1.3

3.73

4.73

umol/l

—

Abrasion of teeth

466

1.12

0.39

1.4

1.2

4.50

4.83

umol/l

0.30

431

Hard cardiovascular diseases

691

0.91

0.39

1.1

1.3

2.21

3.45

umol/l

5.56

634

Redundant prepuce, phimosis and paraphimosis

141

1.27

0.39

1.0

1.4

3.11

4.68

umol/l

1.54

129

Coxarthrosis [arthrosis of hip](FG)

438

1.12

0.39

1.1

1.3

2.75

3.35

umol/l

0.66

402

Coxarthrosis

385

1.13

0.38

1.1

1.2

2.88

3.44

umol/l

0.54

356

Contraceptive management

138

897

1.08

0.38

1.4

1.3

5.34

5.53

umol/l

0.23

130

824

146

1213

1.08

0.38

1.1

1.3

4.63

5.18

umol/l

1.11

134

1115

Degeneration of macula and posterior pole

307

1.16

0.37

1.2

1.3

2.46

2.67

umol/l

0.23

282

Other disorders of veins

673

0.89

0.37

1.2

1.3

3.75

3.97

umol/l

0.18

617

Carcinoma in situ of breast, intraductal

113

0.71

0.37

1.0

1.4

2.51

3.13

umol/l

—

107

Carcinoma in situ of breast, intraductal

116

0.69

0.37

1.0

1.4

2.51

3.52

umol/l

—

104

Malignant neoplasm of corpus uteri

1.29

0.36

1.0

1.6

4.18

2.38

umol/l

—

Ulcerative colitis

582

1.12

0.36

1.3

1.2

3.28

5.37

umol/l

6.00

538

Other congenital malformations of tongue, mouth and pharynx

0.64

0.36

3.6

1.5

5.03

5.15

umol/l

—

Parkinson's disease

1.33

0.35

1.7

1.3

3.63

2.39

umol/l

1.35

Other juvenile arthritis

212

0.80

0.35

1.8

1.3

5.94

5.65

umol/l

0.09

195

Ulcerative rectosigmoiditis

144

1.25

0.35

1.3

3.16

5.10

umol/l

2.83

137

Twin gestation

373

0.86

0.34

1.4

1.3

4.61

5.28

umol/l

0.68

344

Primary coxarthrosis, bilateral

218

1.19

0.34

1.2

1.3

2.23

2.52

umol/l

0.24

202

Emergency coronary revascularization (for ACS)

314

0.87

0.34

1.0

1.2

1.97

2.93

umol/l

2.08

284

Blepharochalasis

274

1.17

0.33

1.2

1.3

1.95

2.85

umol/l

1.49

248

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

109

1.29

0.33

1.4

1.3

2.13

4.52

umol/l

4.45

100

Pre-eclampsia or poor fetal growth

143

1333

1.07

0.33

1.3

5.24

5.50

umol/l

0.43

130

1236

Multiple gestation

382

0.86

0.33

1.4

1.3

4.65

5.26

umol/l

0.63

352

Finngen Rheumatological endpoints

305

1821

0.95

0.33

1.3

4.17

5.37

umol/l

6.55

271

1687

Other arthritis (FG)

682

1.10

0.33

1.3

3.51

4.91

umol/l

3.53

635

Myocardial infarction

335

0.88

0.32

1.1

1.2

1.68

2.96

umol/l

5.78

307

Bleeding

165

1128

1.06

0.32

1.3

3.90

4.34

umol/l

0.35

151

1034

Other inflammation of vagina/vulva

119

1.26

0.31

2.1

1.2

4.65

5.50

umol/l

0.52

112

Parkinson's disease, including avohilmo

1.30

0.31

1.7

1.4

3.63

2.43

umol/l

1.29

All pneumoniae

312

2060

1.05

0.31

1.4

1.3

4.39

5.03

umol/l

2.30

281

1899

Ankyloglossia

0.72

0.31

3.1

1.4

4.15

4.98

umol/l

—

Disorders of vitreous body

605

1.10

0.30

1.3

2.47

3.32

umol/l

1.78

558

Leiomyoma of uterus

136

716

1.07

0.30

1.4

1.3

3.42

4.49

umol/l

3.69

126

657

All dysplastic lesions of the cervix uteri

108

1158

0.93

0.30

1.4

1.3

6.14

5.46

umol/l

1.18

101

1066

Ischaemic Stroke, excluding all haemorrhages

422

0.90

0.30

1.2

2.40

3.13

umol/l

1.59

384

Respiratory distress of newborn

120

1.24

0.29

2.0

1.8

3.65

3.49

umol/l

0.09

105

HSIL lesion of the cervix uteri, vagina or vulva

858

0.92

0.29

1.4

1.3

6.01

5.49

umol/l

0.62

791

Acute appendicitis, no complications

167

1576

1.06

0.28

1.2

1.3

4.84

5.15

umol/l

0.53

154

1453

Ankylosing spondylitis, ICD10

140

0.79

0.28

1.3

3.06

4.86

umol/l

0.78

134

Pediculosis, acariasis and other infestations

1.28

0.28

1.6

1.1

6.38

5.63

umol/l

0.36

Hemiplegia

1.27

0.27

1.1

1.2

3.31

5.08

umol/l

—

HSIL lesion of the cervix uteri

823

0.92

0.27

1.4

1.2

6.05

5.54

umol/l

0.58

763

Pedestrian injured in transport accident

104

1.25

0.26

2.2

1.2

3.76

5.00

umol/l

0.63

Inflammatory disorders of breast

254

1.14

0.25

1.7

1.2

5.42

5.98

umol/l

0.28

235

Presence of cardiac and vascular implants and grafts

298

0.89

0.25

1.0

1.3

1.92

3.17

umol/l

2.97

269

Nail disorders

114

1.23

0.25

1.2

1.4

4.72

4.97

umol/l

0.11

108

Disorders of vitreous body and globe

621

1.08

0.24

1.3

2.44

3.30

umol/l

1.83

572

Other heart diseases, wide

272

1753

0.96

0.24

1.3

3.82

5.11

umol/l

7.93

246

1614

Second line medication for Crohn's disease

153

1455

1.05

0.23

1.3

3.60

4.90

umol/l

4.91

134

1338

Other benign neoplasms of uterus

1.32

0.23

1.4

1.3

1.10

3.28

umol/l

—

Vestibular neuronitis

1.24

0.23

2.3

1.3

4.47

4.12

umol/l

0.21

Acute and subacute iridocyclitis

333

1.11

0.22

1.5

1.3

3.81

4.69

umol/l

0.75

312

Gestational [pregnancy-induced] hypertension

117

1105

1.06

0.22

1.3

5.28

5.40

umol/l

0.17

112

1019

Complications of the puerperium, not elsewhere classified

167

0.84

0.21

1.1

1.2

5.58

5.68

umol/l

0.04

159

Osteogenesis imperfecta

0.00

0.21

0.0

2.4

—

3.69

—

Complications of anaesthesia during the puerperium

0.00

0.21

0.0

1.2

—

6.66

—

Palindromic rheumatism

0.00

0.21

0.0

1.1

—

4.18

—

Benign neoplasm: Connective and other soft tissue, unspecified

0.00

0.21

0.0

1.0

—

4.64

—

Carcinoma in situ of breast, other/unspecified

0.00

0.21

0.0

2.0

—

1.84

—

Carcinoma in situ of breast, other/unspecified

0.00

0.21

0.0

1.3

—

1.78

—

Shoulder region

0.00

0.21

0.0

1.2

—

5.84

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.21

0.0

1.1

—

5.22

—

Other crystal arthropathies

0.00

0.21

0.0

1.0

—

2.73

—

Benign neoplasm: Connective and other soft tissue, unspecified

0.00

0.21

0.0

1.1

—

3.96

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

1.99

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

196

1329

0.96

0.21

1.4

1.3

3.71

4.34

umol/l

1.98

175

1219

Inflammatory bowel disease

837

1.06

0.21

1.4

1.3

3.47

5.31

umol/l

6.56

776

Ulcerative colitis (strict) with PSC

0.00

0.21

0.0

1.1

—

5.81

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.21

0.0

1.2

—

3.78

—

Obstructed labour due to malposition and malpresentation of fetus

919

0.94

0.20

1.2

1.3

5.17

5.39

umol/l

0.26

844

Colitis, primary sclerosing, strict definition

0.00

0.20

0.0

1.0

—

6.66

—

Injury of nerves at forearm level

0.00

0.20

0.0

1.2

—

7.68

—

Poor fetal growth

666

0.93

0.20

1.2

1.3

5.70

5.93

umol/l

0.24

623

Sudden idiopathic hearing loss

108

1.20

0.20

2.0

1.3

4.28

4.54

umol/l

0.13

100

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.22

0.19

1.1

1.3

5.51

5.32

umol/l

0.07

L04AX Other immunosuppressants

146

1398

1.04

0.19

1.3

3.67

4.87

umol/l

4.04

128

1285

Unspecified fall

123

1164

1.05

0.18

1.3

4.71

5.03

umol/l

0.42

109

1074

Coronary revascularization (ANGIO or CABG)

283

0.91

0.18

1.0

1.2

2.01

3.10

umol/l

2.37

256

Injuries to the head

359

2276

1.03

0.18

1.3

4.66

5.20

umol/l

2.06

324

2105

Other disorders of ear

217

1396

1.04

0.18

1.3

3.67

4.56

umol/l

3.22

193

1291

Lichen sclerosus et atrophicus

128

1.17

0.18

1.1

1.4

3.09

3.83

umol/l

0.48

114

Skin changes due to chronic exposure to nonionizing radiation

257

1.10

0.17

1.2

1.3

1.16

2.28

umol/l

2.77

233

Toxic effect of contact with venomous animals

0.76

0.17

1.8

1.3

5.72

5.05

umol/l

—

Juvenile rheumatoid arthirtis

1.16

0.16

2.0

1.3

4.34

5.78

umol/l

—

Maternal care for known or suspected abnormality of pelvic organs

120

864

0.96

0.16

1.2

1.3

5.41

5.66

umol/l

0.32

114

800

LSIL lesion of the cervix uteri, vagina or vulva

545

1.06

0.15

1.5

1.3

5.22

5.38

umol/l

0.14

515

303

1.09

0.15

1.1

1.2

1.43

2.69

umol/l

3.03

276

Chronic iridocyclitis

1.13

0.15

1.2

5.48

5.11

umol/l

—

Injuries to the hip and thigh

704

0.95

0.15

1.4

1.3

4.52

4.74

umol/l

0.21

649

Alzheimer’s disease (Late onset)

0.78

0.14

1.0

1.4

2.33

2.02

umol/l

—

Benign mammary dysplasia

217

1.11

0.14

1.8

1.2

2.81

4.22

umol/l

1.39

204

Fracture of shoulder and upper arm

706

0.95

0.14

1.4

1.2

4.62

5.10

umol/l

0.45

651

Type1 diabetes, definitions combined, early onset

332

1.08

0.14

1.5

1.4

4.51

5.47

umol/l

1.34

303

IBD patients in KELA-register

626

1.05

0.14

1.3

3.36

5.61

umol/l

6.80

583

Coxarthrosis, primary, with hip surgery

381

1.07

0.13

1.2

1.3

2.75

2.45

umol/l

0.23

347

Cardiomyopathies, Primary/intrinsic

106

0.85

0.13

1.2

1.3

2.81

3.63

umol/l

—

Coronary atherosclerosis

480

1.05

0.13

1.4

1.2

1.95

3.01

umol/l

4.35

443

Meniscus derangement

617

1.04

0.12

1.4

1.2

3.25

4.05

umol/l

1.37

570

Iridocyclitis

413

1.07

0.12

1.4

1.3

3.56

4.63

umol/l

1.25

387

In situ neoplasms

670

0.95

0.12

1.2

1.3

4.88

4.89

umol/l

0.01

627

Other strabismus

745

1.04

0.12

1.5

1.3

5.41

5.32

umol/l

0.07

684

Hernia

208

1444

0.98

0.11

1.3

3.88

4.52

umol/l

0.76

193

1318

Lung diseases due to external agents

105

1.14

0.11

2.3

1.2

4.38

3.71

umol/l

0.40

Tooth eruption problems

888

1.04

0.11

1.4

1.3

6.44

6.40

umol/l

0.03

828

Strabismus

837

1.04

0.10

1.4

1.3

5.21

5.31

umol/l

0.08

772

Open wound of head

978

0.97

0.10

1.3

4.17

4.86

umol/l

1.37

899

Superficial injury of lower leg

698

0.96

0.10

1.4

1.2

5.28

5.61

umol/l

0.33

649

In situ neoplasms

698

0.96

0.10

1.2

1.3

4.88

4.81

umol/l

0.06

651

Generalized epilepsy

125

1.12

0.10

1.1

1.2

5.41

5.31

umol/l

0.04

116

Other heart diseases

144

926

1.03

0.10

1.3

3.92

5.16

umol/l

4.03

128

851

Inflammatory bowel disease, strict (require KELA)

634

1.04

0.09

1.3

3.36

5.56

umol/l

6.54

591

Actinic keratosis

239

1.07

0.09

1.1

1.3

0.90

2.24

umol/l

8.31

216

Other/unspecified enthesopathies of lower limb, excluding foot

116

1.12

0.09

1.6

1.2

3.54

4.90

umol/l

0.61

111

Other and unspecified disorders of vitreous body

465

1.05

0.09

1.3

1.91

3.11

umol/l

3.57

429

Ankylosing spondylitis

124

0.89

0.09

1.3

1.2

3.06

5.02

umol/l

0.87

118

Anterior Iridocyclitis

360

1.06

0.09

1.5

1.3

3.78

4.69

umol/l

0.82

336

Major coronary heart disease event

498

0.96

0.09

1.0

1.2

1.69

2.98

umol/l

7.40

456

Malignant neoplasm of ovary

0.82

0.08

1.2

1.4

4.00

3.78

umol/l

—

Benign neoplasm of other and unspecified female genital organs

1.04

0.08

1.4

5.36

4.73

umol/l

—

Benign neoplasm of other and unspecified female genital organs

1.03

0.07

1.4

5.36

4.57

umol/l

—

Parodontitis or/and operation codes

175

1020

1.02

0.07

1.2

1.3

3.82

4.78

umol/l

3.15

152

951

Reimbursement for rheumatic diseases

134

1366

0.98

0.07

1.3

3.74

4.71

umol/l

2.59

121

1253

Cardiomyopathy (excluding other)

112

0.89

0.07

1.2

1.3

2.77

3.76

umol/l

—

105

Heart failure, strict

374

0.96

0.07

1.5

1.2

2.41

2.94

umol/l

0.67

337

Pregnancy with abortive outcome

287

1521

0.99

0.07

1.2

5.73

5.59

umol/l

0.26

270

1408

Coxarthrosis, primary

512

1.03

0.07

1.1

1.3

2.82

2.79

umol/l

0.02

468

Other complications of labour and delivery, not elsewhere classified

724

0.97

0.07

1.1

1.2

6.53

6.19

umol/l

0.51

675

All dysplastic lesions of the cervix uteri, vagina or vulva

120

1218

0.98

0.07

1.4

1.3

5.95

5.36

umol/l

1.01

110

1125

Embedded teeth, including avohilmo

478

0.96

0.06

1.6

1.2

6.06

6.56

umol/l

0.40

446

Varicose veins

728

0.98

0.06

1.4

1.3

2.78

3.39

umol/l

1.18

664

Scissor bite

162

0.92

0.06

1.1

1.5

5.08

5.33

umol/l

0.14

151

All-cause Heart Failure

372

0.97

0.05

1.5

1.2

2.41

2.94

umol/l

0.68

335

Dislocation, sprain and strain of joints and ligaments of elbow

161

0.93

0.05

1.1

1.4

7.80

5.55

umol/l

1.08

150

Complications predominantly related to the puerperium

110

1081

1.02

0.05

1.5

1.2

4.30

5.51

umol/l

4.20

105

998

malignant neoplasm of female genital organs

179

1.06

0.05

1.2

1.3

4.53

3.59

umol/l

0.61

165

Iron deficiency anaemia secondary to blood loss (chronic)

189

1.06

0.04

1.4

2.46

4.04

umol/l

2.40

174

Artificial joint operation, meniscal resection

149

977

1.01

0.04

1.3

2.85

3.87

umol/l

3.48

140

891

Caught, crushed, jammed or pinched in or between objects

1.10

0.04

1.9

1.2

4.86

5.26

umol/l

—

Childhood allergy (age < 16)

129

1047

1.01

0.04

1.2

1.3

5.89

6.68

umol/l

1.71

121

976

Event of undetermined intent

111

1.08

0.04

1.2

1.3

5.97

5.80

umol/l

0.08

106

Striking against or struck by other objects

944

1.02

0.04

1.4

1.3

5.28

5.53

umol/l

0.29

871

Gout, strict definition

102

1.08

0.03

1.0

1.3

2.87

2.82

umol/l

0.03

Antenatal screening

135

768

0.99

0.02

1.2

1.3

6.18

6.06

umol/l

0.16

129

706

Congenital malformations of the urinary system

148

0.95

0.02

1.1

1.3

5.01

5.06

umol/l

0.02

137

Heart failure,strict

346

1.02

0.02

1.5

1.2

2.47

3.00

umol/l

0.68

320

Asthma/COPD (KELA code 203)

304

2154

0.99

0.02

1.4

1.3

4.10

5.35

umol/l

3.46

278

1995

Supervision of normal pregnancy

128

739

0.99

0.02

1.2

1.3

5.90

6.06

umol/l

0.20

118

679

Other hammer toe(s) (acquired)

148

0.95

0.02

1.1

1.2

2.73

2.90

umol/l

0.07

138

Major coronary heart disease event excluding revascularizations

435

0.98

0.02

1.0

1.2

1.57

2.85

umol/l

8.37

399

Injuries to the elbow and forearm

205

1862

0.99

0.01

1.2

1.3

5.26

umol/l

0.00

186

1725

Covid-19 suspected case

773

1.01

0.01

1.2

5.47

5.77

umol/l

0.29

721

Labour and delivery complicated by fetal stress [distress]

148

990

1.00

0.00

1.3

1.2

5.97

6.04

umol/l

0.08

141

914

Single delivery by caesarean section

135

778

1.00

0.00

1.3

1.2

5.82

6.13

umol/l

0.39

129

722

Any event in cancer register

260

1541

1.00

0.00

1.3

3.89

4.84

umol/l

4.26

235

1417

Hordeolum and other deep inflammation of eyelid

104

0.96

0.00

1.2

1.4

5.63

5.28

umol/l

—

Alzheimer’s disease, wide definition

0.98

0.00

1.1

1.3

3.97

1.98

umol/l

—

Other congenital malformations of the digestive system

159

1.00

0.00

2.0

1.5

4.53

4.62

umol/l

0.03

143

Tubulo-interstitial nephritis, not specified as acute or chronic

106

1.04

0.00

1.4

1.2

2.79

4.82

umol/l

1.36

100

Leiomyoma of uterus

152

863

1.00

0.00

1.3

3.31

4.11

umol/l

2.63

138

788

Common variable immunodeficiency

0.00

0.0

1.1

—

8.35

—

Heart failure and hypertrophic cardiomyopathy

0.00

0.0

1.0

—

3.30

—

Other specified and unspecified disorders of lens

0.00

0.0

1.0

—

3.90

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.0

—

7.32

—

Degeneration of nervous system due to alcohol

0.00

0.0

1.0

—

2.10

—

Degeneration of the brain due to alcohol

0.00

0.0

1.0

—

2.10

—

Pemphigus

0.00

0.0

1.0

—

10.56

—

Malignant neoplasm of oesophagus

0.00

0.0

1.0

—

1.64

—

Other diseases of arteries and capillaries

0.92

0.00

1.3

3.70

4.41

umol/l

—

Calcific tendinitis

0.00

0.0

1.0

—

3.97

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

2.88

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.92

0.00

1.0

1.2

2.01

4.33

umol/l

—

Endometroid carcinoma of ovary

0.00

0.0

1.0

—

1.88

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

1.95

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

3.00

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

4.04

—

Mucinous and mucinous cystic tumor

0.00

0.0

1.0

—

6.30

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

0.0

1.0

—

1.76

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

3.14

—

Malignant neoplasm of small intestine

0.00

0.0

1.0

—

2.25

—

Exfoliative dermatitis

0.00

0.0

1.0

—

4.40

—

Pulmonary eosinophilia, not elsewhere classified

0.00

0.0

1.0

—

3.90

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

1.0

—

2.42

—

Benign neoplasm: Oesophagus

0.00

0.0

1.2

—

4.12

—

Carcinoma in situ of colon

0.00

0.0

1.0

—

3.86

—

Congenital hydrocephalus

0.00

0.0

1.0

—

7.44

—

Otosclerosis

0.94

0.00

1.1

1.3

3.87

3.90

umol/l

—

Memory loss

1.01

0.00

1.7

1.3

2.78

3.53

umol/l

—

Benign neoplasm: Appendix

0.00

0.0

1.0

—

2.24

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

1.70

—

Other and unspecified acquired haemolytic anaemias

0.00

0.0

1.0

—

3.99

—

Alcoholic gastritis

0.00

0.0

1.0

—

2.38

—

Other disorders of choroid

0.00

0.0

1.0

—

4.86

—

Isolated proteinuria with specified morphological lesion

0.00

0.0

1.1

—

5.67

—

Sleepwalking [somnambulism]

0.00

0.0

1.2

—

9.34

—

Other acquired deformities of ankle and foot

0.00

0.0

1.0

—

4.12

—

Lesion of femoral nerve

0.00

0.0

1.0

—

4.80

—

Lumbosacral root disorders, not elsewhere classified

0.00

0.0

1.2

—

1.78

—

Crystal arthropathies, rheuma endpoint

0.00

0.0

1.0

—

5.02

—

Otorrhagia

0.00

0.0

1.0

—

6.10

—

Additional codes for the location of defect, injury or illness

0.91

0.00

1.6

1.3

3.81

5.12

umol/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

0.00

0.0

1.2

—

6.69

—

Other chondrocalcinosis

0.00

0.0

1.0

—

3.96

—

Benign neoplasm: Bronchus and lung

0.00

0.0

1.0

—

3.20

—

Complications of anaesthesia during pregnancy

0.00

0.0

1.0

—

8.23

—

Carcinoma in situ of skin of scalp and neck

0.00

0.0

1.2

—

1.78

—

Carcinoma in situ of colon

0.00

0.0

1.2

—

3.58

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.0

1.2

—

1.62

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.0

1.1

—

2.06

—

Benign neoplasm: Oesophagus

0.00

0.0

1.1

—

3.21

—

Carcinoma in situ of breast, lobular

0.00

0.0

1.4

—

2.14

—

Liveborn infants according to place of birth

0.93

0.00

1.5

1.6

4.05

4.31

umol/l

—

Obstructed labour due to maternal pelvic abnormality

310

1.00

0.00

1.2

1.4

3.60

3.71

umol/l

0.07

283

Fall involving playground equipment

0.98

0.00

2.2

2.1

5.02

3.72

umol/l

—

Exposure to unspecified smoke, fire and flames

0.00

0.0

1.0

—

7.61

—

Severe visual impairment, monocular

0.00

0.0

1.1

—

8.13

—

Benign neoplasm: Bronchus and lung

0.00

0.0

1.0

—

3.58

—

Benign neoplasm: Appendix

0.00

0.0

1.0

—

2.08

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

0.00

0.0

1.0

—

5.97

—

Burns classified according to extent of body surface involved

0.00

0.0

1.5

—

6.94

—

Shock, not elsewhere classified

0.00

0.0

1.6

—

3.27

—

Respiratory disorders in diseases classified elsewhere

0.00

0.0

1.0

—

4.65

—

Abnormal spermatozoa

0.88

0.00

1.0

1.1

1.72

2.77

umol/l

—

Marfan's syndrome

0.00

0.0

1.2

—

7.75

—

Mastocytosis

0.00

0.0

2.6

—

6.89

—

Spina bifida

0.00

0.0

3.2

—

8.52

—

Reduction defects of lower limb

0.00

0.0

1.0

—

9.72

—

Haemolytic disease of fetus and newborn

0.00

0.0

1.6

—

4.35

—

Toxoplasmosis

0.00

0.0

1.0

—

8.12

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

1.88

—

Thrombotic microangiopathy

0.00

0.0

1.3

—

5.45

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS